TSS:Hg 226405.1

Basic information about the TSS

---

TSS ID: hg_226405.1 Species: human Chr: chr16		Start: 67029123 End: 67029130 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000561924.6 Distance: -8 GeneID: 865 HGNC/MGI_ID: HGNC:1539 UniProt_ID: J3KS23

Gene_name: core-binding factor subunit beta Gene_symbol: CBFB Gene_synonyms: PEBP2B Gene_source: HGNC:1539

TATA-Box annotation

---

Distance to TSS:	-22
Nearest PromoterID:	NM_001368707
Entrez ID:	865
Nearest Unigene:	Hs.460988
Nearest Refseq:	NM_001755
Nearest Ensembl:	ENSG00000067955
Gene Name:	core-binding factor subunit beta
Gene Alias:	PEBP2B
Gene Description:	core-binding factor subunit beta
Gene Type:	protein-coding
CpG%:	0.17
GC%:	0.820896
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CBFB p2@CBFB p3@CBFB p4@CBFB p5@CBFB p7@CBFB p8@CBFB p9@CBFB p10@CBFB
Sample		p1@CBFB	p2@CBFB	p3@CBFB	p4@CBFB	p5@CBFB	p7@CBFB	p8@CBFB	p9@CBFB	p10@CBFB
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	20.65	6.62	1.17	1.36	0.39	0.58	0.39	0.00	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	20.84	9.71	0.40	1.42	0.61	0.20	0.20	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	16.78	10.61	0.77	0.96	0.77	0.96	0.39	0.19	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	13.93	8.11	1.25	1.66	0.42	0.21	1.46	0.21	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	17.77	6.75	0.45	0.67	0.90	0.67	0.45	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	14.34	6.20	0.39	0.39	0.19	0.58	0.78	0.19	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	21.35	8.28	0.22	1.96	0.65	0.87	0.44	0.22	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	21.56	6.78	0.24	0.73	0.24	0.73	0.48	0.24	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	22.01	9.62	1.07	0.21	1.28	0.43	1.07	0.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	12.17	9.27	1.74	0.00	0.58	0.00	0.58	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	10.91	9.30	0.00	0.00	0.40	0.00	1.21	0.81	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	15.04	8.54	0.81	1.22	0.81	0.81	0.00	1.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	5.48	2.26	1.45	0.00	0.00	0.16	0.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	5.26	2.86	0.60	0.15	0.15	0.45	0.30	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	6.37	1.76	1.10	0.00	0.66	0.00	0.22	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	4.78	3.27	0.25	0.50	0.50	0.00	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	2.62	1.53	0.44	0.22	0.44	0.00	0.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	2.95	0.84	0.42	0.42	0.00	0.42	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	3.20	2.13	0.53	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	3.16	2.56	1.50	0.00	0.30	0.30	0.75	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	4.54	2.54	1.07	0.00	0.27	0.27	0.40	0.00	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	6.56	2.42	1.21	0.17	0.35	0.52	0.52	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	5.56	2.59	1.42	0.39	0.00	0.00	0.13	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	4.85	1.21	0.73	0.49	0.49	0.24	0.00	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	4.39	2.58	0.77	1.03	0.52	0.26	0.52	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	3.17	2.53	0.63	0.32	0.00	0.00	0.63	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	2.20	3.85	1.10	0.55	0.55	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	7.31	6.13	0.71	0.24	0.71	0.24	0.71	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	5.49	1.78	1.29	1.13	0.48	0.16	0.65	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	5.97	4.89	0.90	0.90	0.36	0.00	0.72	0.00	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	5.02	3.98	0.84	1.05	0.00	0.21	0.00	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	3.71	5.47	0.59	0.39	0.59	0.39	0.39	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	6.12	5.49	0.42	0.63	0.42	0.42	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	3.63	5.28	0.66	0.49	0.33	0.16	0.00	0.16	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	6.17	6.17	1.12	1.12	0.00	0.37	0.00	0.00	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	4.60	5.17	0.77	1.15	0.77	0.38	0.38	0.00	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	5.72	5.31	1.02	1.43	0.41	0.00	0.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	7.25	5.24	1.21	1.81	0.60	0.20	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	4.32	5.13	0.81	1.89	0.00	0.27	0.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	8.16	3.60	1.44	1.20	0.72	0.72	0.72	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	3.76	5.18	0.94	1.18	0.24	0.24	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	5.56	4.83	0.59	1.02	0.44	0.00	0.73	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	6.54	4.01	0.63	0.63	0.21	0.21	0.63	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	6.64	4.55	0.70	1.40	0.35	0.35	0.17	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	5.82	4.62	0.60	1.20	0.20	0.60	0.40	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	6.75	3.02	0.93	0.70	0.00	0.23	0.23	0.00	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	6.96	4.56	0.48	0.96	0.48	0.00	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	4.77	5.96	0.00	1.19	0.89	0.30	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	8.38	5.27	0.48	0.96	0.48	0.96	0.72	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	7.28	4.45	1.21	1.42	0.20	0.20	0.00	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	5.74	4.30	0.82	0.82	0.00	0.00	0.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	4.45	3.34	0.44	0.67	0.22	0.22	0.67	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	27.98	13.99	0.00	0.00	0.00	97.95	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	5.68	2.84	0.35	1.06	0.00	0.35	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	4.64	2.32	0.33	0.33	0.00	0.00	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	10.91	11.75	0.00	0.00	0.00	0.00	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	7.35	2.30	0.92	0.92	0.46	1.84	0.92	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	4.86	4.86	0.32	0.65	0.32	0.32	0.65	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	2.89	4.50	0.00	0.00	0.64	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	4.40	3.77	0.63	1.26	0.31	0.00	0.31	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	2.82	2.82	0.00	0.71	0.71	0.00	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	3.36	1.12	0.00	0.00	0.00	0.56	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	4.78	6.37	0.00	0.00	0.00	0.00	1.59	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	3.06	4.76	0.00	1.70	0.00	0.34	0.34	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	3.90	3.57	0.00	0.65	0.32	0.32	1.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	3.19	2.84	0.71	0.71	0.00	0.00	0.71	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	16.16	0.00	0.00	0.00	0.00	113.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	47.38	0.00	15.79	0.00	0.00	0.00	15.79	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	3.90	5.36	0.00	0.98	0.49	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	6.45	2.98	0.99	0.50	0.99	0.50	0.50	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	2.81	3.75	0.00	0.47	0.47	0.47	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	5.63	2.32	0.33	0.66	0.99	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	4.02	2.78	0.00	0.62	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	3.97	4.28	1.53	0.00	0.00	0.00	0.31	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	13.94	8.71	1.58	2.69	0.63	1.90	0.16	0.32	0.32
Adipocyte - breast, donor2	11327-117E4	7.06	4.33	1.60	1.28	0.48	0.16	0.00	0.00	0.16
Adipocyte - omental, donor1	11473-119C6	11.96	7.25	1.15	1.53	0.89	0.64	0.00	0.13	0.13
Adipocyte - omental, donor2	11474-119C7	5.98	5.98	0.00	0.75	0.75	0.75	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	5.69	2.01	1.34	0.00	1.34	0.00	0.00	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	7.02	2.55	0.64	0.00	1.28	0.00	0.00	0.00	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	1.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	8.13	2.71	1.35	0.45	0.90	0.00	0.00	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	3.30	1.22	0.00	0.35	0.35	0.00	0.00	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	12.32	1.17	2.35	0.78	0.39	0.20	0.20	0.00	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	7.21	1.80	0.51	0.00	0.00	0.00	0.00	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	6.41	0.84	0.28	0.00	0.00	0.00	0.28	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	12.93	2.94	2.35	1.18	0.00	0.00	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	8.12	1.85	2.17	0.40	0.56	0.16	0.16	0.08	0.48
Adipocyte differentiation, day08, donor2	13023-139D8	9.36	2.26	1.94	0.32	0.32	0.00	0.00	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	4.27	1.60	1.07	0.00	0.00	0.00	1.60	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	4.45	1.67	0.56	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	4.16	0.42	0.42	0.00	0.42	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	4.77	2.26	0.50	0.00	0.00	0.00	0.25	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	2.62	0.98	0.98	0.65	0.00	0.33	0.00	0.00	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	4.57	1.52	2.13	0.30	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	9.28	1.77	1.33	0.66	0.22	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	2.51	0.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	3.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	8.46	1.98	2.34	0.00	0.18	0.00	0.00	0.00	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	6.57	1.03	2.26	1.03	0.00	0.00	0.00	0.00	0.21
Anulus Pulposus Cell, donor1	11248-116E6	5.03	4.23	0.92	0.11	0.46	0.23	0.11	0.11	0.00
Anulus Pulposus Cell, donor2	11463-119B5	4.41	2.45	1.22	0.24	0.98	0.24	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	6.29	0.45	0.45	1.35	0.00	0.00	0.90	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	3.47	1.74	1.74	0.87	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	17.12	0.00	0.00	0.00	0.00	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	6.88	1.20	1.79	0.00	0.30	0.30	0.00	0.00	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	11.38	2.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	4.62	0.66	0.66	0.66	0.66	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	7.15	2.92	0.97	1.30	0.32	0.97	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	3.40	2.43	1.94	0.00	0.00	0.00	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	6.53	0.59	0.59	0.00	0.00	0.59	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	7.16	2.26	1.13	0.38	0.38	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	4.35	2.18	0.73	0.73	0.00	0.00	0.00	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	2.51	2.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	10.38	2.64	1.65	0.66	0.49	0.00	0.00	0.33	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	2.73	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	7.39	1.21	1.36	0.15	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	3.75	4.29	0.54	0.00	0.00	0.54	0.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	8.69	2.08	1.70	0.76	0.00	0.00	0.00	0.00	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	6.95	2.14	0.53	0.53	0.00	0.27	0.00	0.00	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	6.83	1.95	1.95	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	7.80	2.82	1.99	0.83	0.00	0.00	0.00	0.17	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	10.81	1.20	1.20	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	0.00	0.00	0.00	0.00	0.00	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	8.40	1.72	1.03	0.34	0.17	0.17	0.00	0.00	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	5.34	2.91	0.97	0.00	0.49	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	8.35	1.14	2.28	0.38	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	3.63	1.21	1.21	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	5.13	2.85	1.71	0.00	0.00	0.57	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	10.26	2.78	2.99	0.43	0.64	0.00	0.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	5.42	1.81	0.77	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	4.69	1.41	0.47	0.47	0.00	0.47	0.00	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	9.00	2.25	0.96	0.00	0.00	0.32	0.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	5.71	2.85	0.00	0.71	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	8.19	3.51	1.75	0.00	0.58	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	7.83	1.81	0.30	0.00	0.00	0.30	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	7.13	1.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	5.09	0.00	2.03	0.00	0.00	0.00	0.00	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	7.64	2.55	0.51	0.25	0.25	0.25	0.00	0.00	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	8.26	2.54	0.00	0.00	0.00	0.00	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	6.04	2.59	2.59	0.00	0.00	0.00	0.00	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	7.62	0.85	1.48	0.85	0.00	0.00	0.00	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	2.90	0.58	0.87	0.58	0.00	0.00	0.00	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	10.39	2.83	0.94	0.94	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	8.65	1.02	1.53	0.00	0.17	0.00	0.00	0.17	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	2.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	9.01	3.00	1.29	0.00	0.64	0.00	0.00	0.00	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	5.41	4.21	0.60	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	5.83	2.19	1.46	0.00	0.00	0.00	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	8.51	1.61	1.15	0.92	0.92	0.00	0.00	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	0.00	2.55	0.00	5.10	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	8.14	1.78	0.25	0.00	0.25	0.25	0.00	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	8.05	1.65	0.83	0.83	0.62	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	8.87	1.22	0.61	0.31	0.31	0.31	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	7.65	1.91	1.43	0.00	0.48	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	8.87	2.00	1.33	0.67	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	1.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	6.09	2.77	0.55	1.66	0.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	12.18	2.91	1.59	0.00	0.53	0.26	0.00	0.00	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	3.27	1.09	0.00	0.36	0.36	0.36	0.00	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	14.00	2.46	2.70	0.12	0.61	0.49	0.00	0.12	0.00
Astrocyte - cerebellum, donor2	11580-120F5	11.47	2.57	2.74	0.00	0.51	0.51	0.00	0.17	0.68
Astrocyte - cerebellum, donor3	11661-122F5	3.36	1.05	1.68	0.00	0.00	0.00	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	21.61	8.02	1.39	0.00	0.35	0.00	0.35	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	23.13	7.28	3.72	1.13	1.29	0.49	0.32	0.00	0.97
Astrocyte - cerebral cortex, donor3	11392-118C6	28.04	8.95	4.33	0.30	1.34	0.30	0.45	0.00	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	50.00	12.62	6.77	1.49	0.69	0.46	0.80	0.80	1.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	52.87	10.65	7.14	1.13	1.25	1.25	1.88	1.00	1.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	48.02	9.33	8.19	1.25	0.68	0.46	0.68	0.34	1.82
Basophils, donor1	12241-129G9	20.40	3.14	2.35	0.00	0.00	0.00	0.26	0.00	1.05
Basophils, donor2	12242-129H1	19.84	6.86	4.33	2.89	0.72	0.00	0.00	0.36	1.44
Basophils, donor3	12243-129H2	19.55	2.79	4.85	1.03	0.15	0.00	0.15	0.29	2.06
Bronchial Epithelial Cell, donor1	11511-119G8	6.25	0.86	1.29	0.22	0.00	0.00	0.00	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	3.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	7.17	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	11.30	1.26	0.63	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	8.94	0.62	0.42	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	2.99	1.38	0.92	0.00	0.00	0.00	0.00	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	12.42	1.44	1.98	0.18	0.00	0.36	0.18	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	66.99	3.50	5.46	0.10	0.21	0.10	0.93	0.10	0.82
Burkitt's lymphoma cell line:RAJI	10476-106I8	69.64	3.49	5.12	0.70	0.23	0.00	1.63	0.00	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	44.77	1.28	3.20	0.96	0.00	0.32	0.32	0.00	1.28
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	0.00	0.00	10.34	0.00	0.00	0.00	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	19.72	3.38	2.82	0.00	0.00	0.00	0.00	0.00	1.13
CD14+ Monocytes, donor2	11305-117B9	14.29	2.78	2.60	0.00	0.19	0.00	0.19	0.19	0.56
CD14+ Monocytes, donor3	11381-118B4	11.64	2.85	4.83	0.88	0.22	0.00	0.88	0.00	1.10
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	15.57	4.53	3.68	0.00	0.57	0.00	0.28	0.00	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	20.47	6.44	4.17	0.76	0.76	0.00	0.38	0.00	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	15.45	4.60	4.27	0.00	1.31	0.66	0.66	0.33	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	16.62	3.90	2.75	0.72	0.29	0.00	0.29	0.00	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	18.71	3.92	0.91	3.02	0.60	0.30	0.30	0.30	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	28.66	5.69	1.90	2.37	0.24	0.47	0.71	0.47	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	11.05	2.68	0.67	0.17	0.17	0.00	1.17	0.00	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	13.25	3.59	0.00	1.66	0.00	0.55	0.28	0.28	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	18.35	5.95	0.99	1.49	0.50	0.00	0.74	0.00	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	11.36	4.90	1.57	1.17	0.20	0.20	0.39	0.59	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	11.22	3.92	1.07	0.53	0.18	0.18	0.00	0.00	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	9.14	5.01	0.22	1.09	0.00	0.00	0.00	0.65	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	11.47	3.51	2.11	0.47	0.23	0.00	0.00	0.23	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	15.84	4.22	1.06	0.53	0.00	0.00	1.06	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	12.20	2.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	14.43	2.83	2.23	0.59	0.15	0.00	0.45	0.15	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	17.36	4.19	0.80	2.59	0.20	0.20	0.20	0.40	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	20.61	4.16	0.62	1.46	0.62	0.62	0.83	0.21	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	16.24	3.66	1.83	0.69	0.46	0.00	0.00	0.00	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	17.42	5.43	1.58	0.68	0.00	0.00	0.45	0.45	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	15.71	3.06	1.31	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	12.64	2.42	2.42	0.00	0.00	0.00	1.34	0.00	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	10.99	4.01	1.57	0.52	0.35	0.17	0.35	0.17	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	9.26	2.95	1.26	0.84	0.00	0.00	1.26	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	11.76	1.47	1.47	0.55	0.18	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	16.20	2.82	1.06	2.47	0.35	0.00	0.00	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	18.43	3.07	1.32	1.32	0.44	0.00	0.00	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	12.21	5.58	0.87	0.52	0.35	0.52	0.52	0.00	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	8.18	4.09	1.49	2.60	0.00	0.00	0.74	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	9.05	8.62	2.16	2.16	0.43	0.00	0.22	0.22	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	8.60	1.64	0.41	0.41	0.00	0.41	0.41	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	9.27	2.55	1.16	1.39	0.23	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	11.60	2.55	0.23	0.70	0.23	0.23	0.00	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	11.33	2.83	2.18	0.00	0.00	0.00	0.00	0.22	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	13.17	2.31	4.16	0.23	0.00	0.00	0.46	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	13.00	1.95	1.08	0.22	0.22	0.00	0.87	0.22	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	12.92	6.07	2.18	0.47	0.47	0.16	0.16	0.00	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	12.57	4.02	2.45	0.17	0.00	0.17	0.35	0.35	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	21.63	4.46	2.23	0.89	0.45	0.22	0.22	0.00	1.11
CD14-CD16+ Monocytes, donor1	11790-124B8	10.72	1.02	4.34	0.51	0.00	0.00	0.26	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	10.10	1.10	4.17	0.22	0.22	0.00	0.22	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	9.05	2.53	6.32	0.00	0.21	0.00	0.42	0.21	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	50.81	6.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	31.86	4.07	2.03	2.03	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	35.21	3.11	3.11	1.04	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	51.17	3.20	4.26	1.60	0.00	0.00	0.00	0.00	2.13
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	48.25	1.07	6.97	1.61	0.00	0.00	1.07	0.00	1.61
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	30.89	2.81	1.40	1.40	1.40	0.00	0.70	0.00	2.11
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	29.02	1.57	3.14	1.57	0.00	0.00	0.78	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	34.28	3.95	0.00	1.32	0.00	0.00	0.00	0.00	3.95
CD19+ B Cells, donor1	11544-120B5	32.05	3.29	1.64	2.47	0.82	0.00	0.82	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	22.49	2.90	1.45	0.73	0.73	0.00	1.45	0.00	1.45
CD19+ B Cells, donor3	11705-123B4	18.68	1.01	1.51	1.51	0.00	0.00	0.50	0.00	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	0.81	0.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	0.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.40
CD34+ Progenitors, donor1	11545-120B6	21.09	0.00	0.00	4.02	0.00	0.00	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	37.64	1.69	2.25	3.93	0.56	0.00	0.00	1.12	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	51.85	5.64	4.13	1.13	0.00	0.00	0.75	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	42.62	2.03	3.16	1.13	0.45	0.00	0.45	0.45	0.90
CD4+ T Cells, donor1	11225-116C1	53.56	2.14	6.43	2.50	0.00	0.00	0.36	0.36	1.43
CD4+ T Cells, donor2	11306-117C1	46.54	0.61	0.61	1.22	0.61	0.00	1.84	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	39.65	0.91	2.44	2.74	0.30	0.00	0.61	0.30	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	80.65	3.83	2.81	8.93	0.00	0.26	0.26	1.53	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	75.91	3.37	2.70	6.29	0.22	0.00	3.37	2.25	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	78.48	2.87	2.30	5.17	0.29	0.57	1.15	0.86	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	32.71	2.37	1.42	3.32	0.00	0.47	0.00	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	28.09	0.70	0.70	0.00	0.00	0.00	0.70	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	26.37	3.30	0.00	6.59	0.00	0.00	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	49.57	3.47	1.88	4.62	0.00	0.14	0.87	1.16	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	70.33	4.41	1.53	4.07	0.34	0.00	1.53	0.51	1.86
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	66.26	3.22	2.42	4.19	0.00	0.32	1.29	1.29	0.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	26.45	1.79	0.90	2.24	0.00	0.00	0.90	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	27.95	1.75	1.40	0.70	0.35	0.00	0.35	0.00	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	33.88	1.32	3.52	1.76	0.00	0.44	0.44	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	61.98	2.53	0.42	3.79	0.00	0.00	0.84	1.26	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	47.79	4.36	2.91	3.95	0.42	0.21	2.70	0.83	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	47.78	4.34	0.67	3.34	0.00	0.00	2.67	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	37.80	0.27	1.09	1.63	0.00	0.00	0.82	0.27	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	34.30	0.54	0.00	0.54	0.00	0.54	1.07	0.00	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	25.11	0.00	3.59	1.79	0.00	1.79	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	86.97	5.01	3.52	10.94	0.19	0.00	0.93	1.48	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	63.47	1.08	1.73	3.03	0.00	0.43	1.52	0.00	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	65.78	2.10	2.31	2.52	0.63	0.00	1.47	0.00	0.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	39.94	2.02	1.52	1.01	0.00	0.00	0.51	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	41.16	1.73	1.73	0.87	0.00	0.00	0.00	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	40.97	4.79	3.05	1.31	0.00	0.00	0.00	0.00	1.74
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	54.93	2.97	1.48	1.98	0.00	0.00	0.00	0.00	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	59.08	0.92	3.69	2.77	0.00	0.00	1.85	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	53.04	0.00	4.19	1.40	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	67.85	1.38	4.15	1.38	0.28	0.00	0.55	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	60.86	3.44	4.42	1.72	0.25	0.00	0.25	0.74	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	58.52	1.54	3.08	3.08	0.00	0.00	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	60.16	4.30	3.94	1.79	0.00	0.00	0.00	0.00	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	66.48	2.77	2.77	0.00	0.00	0.00	1.38	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	44.20	4.26	1.64	2.95	0.00	0.00	0.98	0.98	1.31
CD8+ T Cells, donor2	11307-117C2	33.79	1.50	1.88	3.75	0.00	0.38	1.13	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	38.13	2.78	3.79	3.53	0.25	0.00	0.50	0.25	1.26
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	8.03	13.08	0.92	1.38	2.75	1.15	0.92	0.46	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	9.59	7.91	1.20	0.24	2.16	2.16	1.20	0.48	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	9.30	12.86	1.09	1.64	1.64	1.09	0.27	0.55	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	4.50	10.81	0.00	0.60	0.60	0.90	0.90	1.20	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	10.32	11.52	0.72	1.44	3.36	1.44	0.96	1.68	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	7.50	14.10	1.14	0.91	2.96	1.59	0.45	1.36	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	10.86	13.04	1.52	0.43	2.17	0.87	0.00	0.87	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	7.11	7.37	0.79	1.58	2.37	0.79	0.79	0.53	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	12.66	10.08	0.47	2.11	2.58	2.11	0.94	1.41	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	12.08	11.17	1.21	0.91	1.81	1.51	0.00	0.91	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	11.04	10.75	1.45	1.45	0.58	1.16	0.29	0.58	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	15.45	9.59	0.53	0.53	1.33	2.40	0.27	0.80	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	11.38	21.89	2.63	0.88	1.75	2.63	2.19	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	16.40	13.66	3.64	0.91	1.37	3.64	0.91	1.37	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	16.41	17.16	0.75	2.98	2.24	0.00	0.75	1.49	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	13.33	14.41	1.08	0.36	3.96	1.44	0.36	1.44	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	5.47	14.39	2.30	0.58	2.01	0.86	0.86	1.15	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	9.43	15.08	0.94	0.94	3.06	1.41	0.47	0.94	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	11.41	15.21	1.58	1.90	3.17	1.90	0.32	2.54	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	11.38	10.46	0.62	0.62	0.92	1.23	0.31	0.92	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	10.90	10.90	1.60	0.64	2.56	2.24	0.32	1.28	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	11.86	9.94	1.53	1.15	2.68	1.53	1.53	0.76	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	11.03	9.46	1.18	0.79	0.79	1.58	1.18	0.79	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	12.86	9.08	0.76	0.00	2.27	0.76	1.51	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	14.45	13.65	0.80	0.80	1.61	5.62	0.00	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	15.39	18.19	0.70	0.70	2.10	2.10	0.00	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	28.05	17.03	3.01	0.00	7.01	2.00	1.00	2.00	0.00
Cardiac Myocyte, donor1	11525-119I4	21.93	5.48	0.00	3.66	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	9.39	1.48	0.99	0.00	0.49	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	17.05	3.37	1.47	0.53	0.11	0.11	0.00	0.00	0.11
Chondrocyte - de diff, donor1	11261-116G1	14.91	4.85	0.35	1.39	1.73	0.35	1.04	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	7.11	2.49	0.36	0.71	0.36	0.36	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	8.99	4.21	1.71	0.46	0.68	0.68	0.11	0.23	0.34
Chondrocyte - re diff, donor2	11339-117F7	25.96	6.27	1.79	1.79	1.79	0.00	0.00	1.79	1.79
Chondrocyte - re diff, donor3	11411-118E7	12.54	4.45	1.21	0.00	0.81	0.40	0.81	0.40	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	21.92	10.33	4.02	0.57	1.15	1.38	0.34	0.11	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	17.96	5.77	3.21	1.07	0.21	1.28	0.21	0.00	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	19.12	9.38	3.36	0.53	0.88	1.06	0.18	0.00	0.88
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	10.09	6.14	3.58	0.46	1.10	0.37	0.64	0.09	0.37
Corneal Epithelial Cells, donor1	11526-119I5	5.71	0.66	0.66	0.00	0.00	0.00	0.00	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	7.96	0.00	1.14	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	7.16	2.56	0.77	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	19.98	32.19	1.49	2.31	1.65	2.97	0.17	7.10	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	23.34	35.64	1.58	0.32	4.73	3.15	0.32	5.05	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	31.06	3.45	6.90	10.35	3.45	0.00	31.06	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	12.85	34.56	0.97	1.94	3.02	1.51	0.32	5.83	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	31.09	1.02	1.37	2.39	0.68	0.00	0.68	0.68	1.37
Dendritic Cells - plasmacytoid, donor2	11309-117C4	22.20	0.65	1.31	1.96	0.00	0.00	0.00	0.65	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	28.55	1.94	2.90	2.42	0.00	0.00	0.00	0.00	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	14.18	1.67	1.67	0.00	0.17	0.17	0.00	0.00	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	9.39	1.17	1.17	0.00	0.00	0.00	0.59	0.00	1.76
Endothelial Cells - Aortic, donor2	11340-117F8	12.73	1.41	1.41	0.28	0.28	0.00	0.00	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	19.27	2.36	1.57	1.18	0.00	0.39	0.00	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	9.60	0.87	2.04	0.00	0.29	0.00	0.00	0.58	0.58
Endothelial Cells - Artery, donor2	11341-117F9	20.70	2.12	1.65	0.24	0.00	0.00	0.24	0.00	0.71
Endothelial Cells - Artery, donor3	11413-118E9	15.60	1.75	1.93	0.18	0.53	0.18	0.35	0.00	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	7.54	2.22	0.89	0.22	0.00	0.00	0.22	0.00	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	7.91	3.04	1.22	0.00	0.30	0.00	0.00	0.30	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	9.30	1.97	1.13	0.00	0.28	0.00	0.28	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	10.10	0.89	1.19	0.00	0.00	0.30	0.00	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	5.21	1.56	1.04	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	6.52	1.28	1.13	0.14	0.00	0.00	0.00	0.14	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	24.41	5.60	0.80	0.00	0.80	0.00	0.40	0.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	12.58	2.10	0.52	0.00	0.00	0.00	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	27.21	4.85	3.35	0.00	0.50	0.37	1.12	0.25	1.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	23.25	3.69	2.39	0.43	0.65	0.22	1.30	0.22	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	33.83	4.76	2.56	0.12	0.73	0.37	0.12	0.49	0.98
Endothelial Cells - Vein, donor1	11267-116G7	18.20	0.00	2.28	0.00	0.00	1.14	0.00	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	14.67	4.19	0.70	0.00	0.70	0.70	0.00	0.70	0.70
Endothelial Cells - Vein, donor3	11416-118F3	21.67	2.67	2.51	0.16	0.31	0.00	0.16	0.16	1.10
Eosinophils, donor1	12244-129H3	45.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	47.86	1.65	8.25	1.65	0.00	0.00	0.00	0.00	3.30
Eosinophils, donor3	12246-129H5	49.94	3.57	3.57	3.57	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	5.38	0.24	0.73	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	9.44	4.11	1.64	0.82	0.00	0.00	0.82	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	1.53	1.75	0.33	0.22	0.22	0.22	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	8.23	3.36	1.52	0.43	0.33	0.43	0.00	0.11	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	18.80	4.97	1.82	1.21	0.85	0.49	0.00	0.24	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	8.05	1.64	2.46	0.41	0.00	0.00	0.00	0.14	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	6.22	2.32	1.69	0.21	0.21	0.11	0.00	0.11	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	9.49	2.11	0.79	0.26	0.26	0.00	0.00	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	19.60	6.31	2.33	1.33	1.00	0.66	0.33	0.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	5.90	2.72	3.63	0.00	0.00	0.00	0.45	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	8.34	0.76	2.27	1.52	0.76	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	7.89	2.84	0.63	0.32	0.32	0.16	0.00	0.00	0.16
Fibroblast - Cardiac, donor4	11452-119A3	14.85	6.06	3.03	0.61	0.30	0.30	0.30	0.30	0.61
Fibroblast - Cardiac, donor5	11456-119A7	13.32	3.43	1.90	0.13	0.38	0.13	0.00	0.00	0.00
Fibroblast - Cardiac, donor6	11460-119B2	16.37	3.49	1.52	1.06	0.45	0.45	0.15	0.45	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	9.11	1.74	1.34	0.13	0.54	0.00	0.00	0.00	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	12.08	3.45	0.86	0.43	0.86	0.00	0.00	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	17.58	1.46	0.00	0.00	0.00	0.00	0.00	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	11.30	3.92	1.15	0.00	0.23	0.00	0.46	0.23	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	6.28	2.37	3.22	0.34	0.51	0.17	0.00	0.00	0.34
Fibroblast - Dermal, donor1	11269-116G9	9.39	4.46	1.88	0.23	0.23	0.00	0.23	0.00	0.47
Fibroblast - Dermal, donor2	11346-117G5	11.79	0.94	0.47	0.94	0.47	0.00	0.47	0.47	0.94
Fibroblast - Dermal, donor3	11418-118F5	13.30	5.56	1.93	0.60	0.60	0.60	0.12	0.00	0.36
Fibroblast - Dermal, donor4	11450-119A1	16.50	4.52	3.39	0.00	0.57	0.34	0.00	0.11	0.34
Fibroblast - Dermal, donor5	11454-119A5	16.40	2.44	1.92	0.17	0.35	0.52	0.17	0.17	0.52
Fibroblast - Dermal, donor6	11458-119A9	21.76	3.25	3.57	0.49	1.62	0.32	0.16	0.32	0.32
Fibroblast - Gingival, donor1	11237-116D4	12.91	2.71	1.46	0.62	0.21	0.42	0.21	0.00	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	14.93	4.19	1.57	0.79	0.52	0.52	0.00	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	17.53	3.82	2.90	0.13	0.53	0.92	0.00	0.00	0.53
Fibroblast - Gingival, donor3	11394-118C8	9.28	5.32	3.09	0.29	1.06	0.10	0.10	0.00	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	9.35	4.16	2.08	1.04	0.00	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	7.22	1.59	2.11	0.00	0.00	0.00	0.00	0.00	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	20.89	6.55	2.03	1.40	0.78	0.62	0.31	0.47	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	17.99	3.65	1.49	0.95	0.54	0.54	0.14	0.27	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	13.76	3.88	2.47	0.35	1.06	0.35	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	11.41	4.83	0.58	0.58	1.02	0.15	0.58	0.29	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	16.50	4.64	1.64	0.82	0.82	0.14	0.14	0.00	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	29.07	4.83	2.19	2.41	1.21	0.33	0.11	0.00	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	13.50	2.93	1.47	0.59	0.00	0.00	0.00	0.00	0.73
Fibroblast - Lung, donor1	11270-116H1	14.95	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	14.92	4.48	2.98	0.00	0.00	0.00	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	19.84	4.22	2.32	0.63	1.27	0.63	0.00	0.00	1.48
Fibroblast - Lymphatic, donor1	11506-119G3	9.16	1.67	0.83	0.83	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	4.20	1.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	1.12	0.00	0.00	0.00	0.28	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	20.70	2.84	2.84	0.41	1.62	0.41	0.00	0.00	0.81
Fibroblast - Mammary, donor2	11620-122A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	17.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	16.29	4.07	3.30	0.39	0.39	0.39	0.19	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	19.57	4.85	1.97	0.30	0.30	0.76	0.00	0.15	1.06
Fibroblast - Periodontal Ligament, donor3	11395-118C9	19.28	3.37	1.84	0.61	0.61	0.61	0.00	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	19.84	3.82	2.67	0.38	0.76	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	9.99	2.43	0.81	0.27	0.00	0.54	0.00	0.00	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	13.80	2.90	2.32	0.35	0.23	0.12	0.00	0.00	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	21.00	4.86	1.88	0.77	0.44	0.44	0.00	0.11	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	19.51	1.83	1.83	0.61	0.20	0.41	0.20	0.00	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	6.01	0.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	3.56	0.79	1.58	0.00	0.00	0.00	0.00	0.00	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	14.09	2.78	0.99	0.99	1.19	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	9.24	2.13	2.66	0.71	0.18	0.36	0.18	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	6.90	4.53	1.38	0.99	0.59	0.39	0.00	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	9.63	3.61	0.60	1.50	0.00	0.00	0.00	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	13.60	4.97	1.84	1.08	1.51	0.97	0.00	0.22	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	9.36	1.27	1.27	0.51	0.25	0.51	0.00	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	10.01	4.10	1.15	0.33	0.49	0.16	0.00	0.00	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	24.46	8.22	1.20	2.61	0.80	0.40	1.40	0.60	0.40
Fibroblast - skin normal, donor2	11561-120D4	18.79	10.55	2.81	3.11	1.00	1.21	0.10	0.20	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	13.00	3.32	1.21	0.91	0.30	0.60	0.60	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	9.61	4.56	1.57	0.50	0.17	0.58	0.08	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	9.40	3.93	2.39	0.00	0.68	0.34	0.00	0.00	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	10.51	3.94	0.33	0.66	0.33	0.33	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	19.60	7.99	1.92	3.52	1.38	0.96	0.11	0.32	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	14.84	4.72	1.69	1.35	0.84	0.51	0.17	0.51	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	6.12	3.45	1.10	0.94	0.78	0.16	0.00	0.00	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	110.80	88.64	22.16	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	13.07	1.74	1.74	0.00	0.87	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	13.35	1.39	2.60	0.17	0.00	0.35	0.00	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	17.18	1.82	2.34	1.04	0.00	0.00	0.00	0.26	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	16.86	1.53	2.04	1.53	0.00	0.51	0.00	0.00	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	9.95	2.30	1.53	0.00	0.00	0.77	0.77	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	13.40	1.91	0.64	0.00	0.64	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	6.85	1.14	1.71	0.00	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	12.96	4.41	2.48	0.28	0.28	0.55	0.00	0.00	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	14.84	5.02	3.42	0.00	0.23	0.68	0.46	0.00	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	8.92	2.77	2.18	0.00	0.00	0.00	0.59	0.00	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	11.10	2.91	4.49	0.26	0.53	0.26	0.79	0.00	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	16.63	6.85	3.26	0.65	0.98	0.00	0.98	0.00	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	8.84	0.00	0.88	0.00	0.00	0.00	0.00	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	11.45	2.54	2.54	0.00	0.00	0.28	0.42	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	14.78	4.43	2.83	0.00	0.49	0.62	0.25	0.00	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	9.94	1.07	2.42	0.00	0.00	0.54	0.81	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	30.48	9.04	3.47	1.12	0.74	0.50	0.00	0.25	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	18.83	4.98	2.21	0.14	0.14	0.00	0.28	0.14	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	13.21	3.25	1.83	0.41	0.20	0.00	0.20	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	19.85	4.34	2.97	0.23	0.46	0.46	0.46	0.00	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	17.31	6.48	3.49	0.50	0.75	0.25	0.00	0.00	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	16.39	2.40	3.50	0.00	0.22	0.00	0.00	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	19.80	6.80	5.91	0.59	0.89	0.30	0.30	0.00	1.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	18.12	6.68	1.91	0.00	0.79	0.64	0.16	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	15.86	5.81	2.23	0.00	0.22	0.22	0.22	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	20.16	4.84	2.42	0.20	0.60	0.00	0.40	0.00	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	22.90	8.65	3.73	0.68	0.85	0.34	0.34	0.17	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	29.62	6.74	3.10	0.62	0.53	0.62	0.18	0.00	0.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	20.71	4.99	1.98	0.52	0.21	0.10	0.00	0.00	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	16.39	3.93	1.71	0.00	0.68	0.00	0.00	0.17	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	21.58	4.98	3.32	0.44	0.44	0.11	0.11	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	26.21	5.91	2.58	0.42	0.17	0.25	0.00	0.00	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	26.54	2.65	2.86	0.41	0.41	0.20	0.00	0.00	1.02
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	21.04	5.36	2.27	0.21	0.21	0.21	0.00	0.00	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	20.06	6.69	2.42	0.81	0.12	0.35	0.35	0.00	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	19.34	3.34	2.33	0.83	0.33	0.17	0.17	0.00	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	12.56	4.19	1.76	0.00	0.44	0.00	0.22	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	20.79	6.15	2.34	0.61	0.00	0.37	0.25	0.00	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	21.40	6.16	3.24	0.65	0.32	0.16	0.16	0.00	1.30
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	17.00	4.49	2.25	0.32	0.00	0.32	0.00	0.00	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	16.39	5.02	2.37	0.66	0.28	0.19	0.00	0.00	1.04
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	19.61	3.80	2.53	0.79	0.00	0.16	0.16	0.00	0.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	16.72	5.17	1.82	0.91	0.30	0.30	0.00	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	20.70	5.23	3.24	1.36	0.84	0.21	0.42	0.00	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	17.56	3.73	2.42	0.22	0.00	0.00	0.22	0.00	1.32
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	18.52	3.65	1.68	0.56	0.28	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	21.67	3.70	2.31	1.02	0.46	0.28	0.00	0.09	0.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	18.99	3.48	2.14	0.80	0.00	0.27	0.27	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	31.37	5.97	2.91	1.07	0.46	0.00	0.15	0.00	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	20.86	6.35	2.07	1.30	0.39	0.00	0.00	0.00	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	16.26	4.07	2.71	0.54	0.27	0.27	0.00	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	15.49	4.24	1.47	0.37	0.18	0.00	0.00	0.00	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	14.91	3.29	1.75	0.44	0.22	0.66	0.22	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	10.91	2.98	2.98	0.00	0.99	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	12.53	4.35	1.32	0.26	0.66	0.40	0.26	0.00	0.79
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	14.32	3.63	1.61	0.40	0.00	0.40	0.00	0.00	1.21
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	10.42	6.86	1.27	0.25	0.76	0.51	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	14.53	1.59	3.38	0.00	0.40	0.00	0.20	0.00	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	10.17	2.77	2.62	0.31	0.00	0.15	0.00	0.00	0.77
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	11.25	1.43	2.86	0.00	0.20	0.00	0.20	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	7.82	2.19	1.56	0.00	0.00	0.63	0.63	0.00	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	10.45	1.41	1.98	0.00	0.00	0.57	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	10.61	2.31	0.92	0.00	0.00	0.46	0.46	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	7.42	2.47	0.00	0.00	0.00	0.00	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	20.89	4.64	2.71	0.77	1.55	0.77	0.39	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	6.42	1.60	0.00	0.00	0.00	0.00	0.00	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	17.39	8.69	1.74	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	19.20	3.91	3.25	0.00	0.98	1.63	0.33	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	15.24	4.12	1.65	0.00	0.41	0.00	0.41	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	19.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	14.26	2.80	2.52	0.28	0.28	0.56	0.84	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	14.38	2.94	1.31	0.65	0.65	0.33	0.33	0.00	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	13.42	4.19	6.71	0.00	0.00	0.00	1.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	15.90	3.82	2.23	0.32	1.27	0.00	0.64	0.00	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	14.61	0.68	3.40	1.70	1.02	0.34	1.36	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	14.62	2.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	16.61	2.29	4.58	0.57	0.57	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	9.47	3.55	1.78	0.30	0.30	0.59	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	16.94	0.00	1.69	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	20.71	4.56	2.49	0.41	0.00	0.41	0.41	0.00	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	14.04	2.99	1.61	0.46	0.46	0.23	0.23	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	0.00	0.00	0.00	0.00	0.00	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	14.99	3.84	1.54	0.00	0.38	0.77	0.00	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	11.08	2.61	0.65	0.33	0.65	0.00	0.33	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	7.36	4.01	2.68	0.00	0.67	0.00	0.00	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	17.34	3.47	1.16	0.00	0.77	0.00	1.16	0.00	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	18.49	8.90	1.03	1.37	1.03	0.00	2.05	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	9.94	2.48	2.48	0.00	2.48	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	14.63	6.61	1.89	0.47	0.94	0.47	0.00	0.00	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	12.67	3.62	1.21	0.00	0.60	0.00	0.60	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	16.28	6.61	2.03	0.00	0.51	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	15.16	7.58	0.80	0.40	0.00	1.20	1.20	0.00	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	15.79	5.92	2.47	0.00	1.48	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	14.17	3.54	3.54	0.00	0.00	0.00	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	18.09	5.25	0.00	1.17	0.00	1.17	1.17	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	13.61	3.07	1.32	0.00	0.00	0.44	0.44	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	15.26	2.54	0.85	0.00	0.85	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	13.13	6.57	1.79	0.60	0.60	0.00	1.19	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	7.28	5.82	0.97	0.49	0.97	0.49	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	6.85	3.42	1.14	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	5.82	2.08	2.49	0.42	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	10.12	2.25	0.00	0.00	0.00	0.00	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	3.17	2.22	0.63	0.00	1.59	0.63	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	2.51	1.67	1.25	0.00	0.42	0.00	0.42	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	18.22	6.15	0.81	2.20	0.70	0.46	0.00	0.23	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	19.92	5.23	1.52	0.84	1.01	0.84	0.17	0.34	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	15.70	9.33	0.68	0.46	1.37	0.68	0.46	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	18.47	7.32	0.98	1.75	0.98	0.33	0.00	0.33	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	17.62	5.37	1.07	0.64	1.07	0.86	0.00	0.00	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	15.29	7.53	2.15	1.72	0.86	0.22	0.00	0.00	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	14.94	4.98	0.87	0.62	0.37	0.37	0.00	0.00	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	10.81	4.63	1.03	1.20	0.51	0.34	0.34	0.17	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	14.10	3.52	0.64	0.64	0.32	0.32	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	8.39	1.12	2.24	0.00	0.56	0.00	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	7.79	0.43	2.60	0.43	0.00	0.00	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	21.15	5.29	0.00	2.64	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	8.82	1.06	1.76	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	0.73	2.91	0.73	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	14.16	2.62	1.75	0.35	0.00	0.00	0.00	0.17	0.00
Hepatocyte, donor1	11523-119I2	2.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	12.93	4.31	2.15	2.15	0.00	0.00	3.23	0.00	0.00
Hepatocyte, donor3	11684-122I1	7.98	1.84	2.45	0.61	0.00	0.00	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	44.38	3.26	0.65	0.65	0.00	0.00	1.31	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	25.87	11.01	4.72	0.35	0.87	0.52	0.52	0.17	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	14.41	2.47	2.47	0.55	0.00	0.55	0.00	0.00	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	12.74	0.00	3.18	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	9.69	0.00	1.38	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	5.13	0.00	0.00	2.56	0.00	0.00	0.00	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	16.24	1.62	3.25	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	6.67	1.67	0.00	0.00	0.00	0.00	0.00	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	18.15	0.00	3.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	13.23	2.65	2.65	1.32	0.00	0.00	0.00	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	14.41	0.00	0.00	0.00	0.00	0.00	0.00	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	20.95	0.00	0.00	0.00	0.00	0.00	0.00	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	6.30	1.89	1.26	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	10.83	1.55	1.55	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	14.21	0.65	1.29	0.65	0.00	0.65	0.00	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	16.10	1.61	3.22	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	17.93	4.89	1.63	2.44	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	15.53	2.94	0.42	0.84	0.00	0.00	0.00	0.42	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	18.48	0.80	0.00	1.61	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	13.85	0.00	0.92	0.92	0.00	0.00	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	15.08	0.00	15.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	11.80	1.89	0.94	0.94	0.00	0.00	0.00	0.47	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	11.79	0.00	0.91	0.00	0.00	0.00	0.00	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	16.14	0.00	0.00	0.00	0.00	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	10.16	1.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	14.03	1.91	0.64	0.00	0.00	0.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	10.94	1.82	0.00	0.00	1.82	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	15.80	15.80	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	15.71	1.43	0.00	3.57	0.00	0.00	0.00	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	19.91	0.00	3.32	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	11.42	1.54	0.62	0.31	0.00	0.00	0.00	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	10.54	1.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	12.52	0.70	1.39	0.70	0.00	0.00	0.00	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	15.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	4.36	0.00	1.74	0.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	13.50	2.25	0.00	0.00	2.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	7.47	2.13	1.07	0.00	0.00	1.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	6.93	0.00	2.77	0.00	2.77	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	14.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	10.12	0.00	0.00	0.00	0.00	0.00	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	18.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	9.52	1.06	1.06	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	6.94	0.73	1.39	0.33	0.16	0.00	0.00	0.00	0.16
Keratinocyte - epidermal, donor2	11349-117G8	1.17	0.00	0.59	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	17.61	1.04	2.08	0.28	0.00	0.00	0.09	0.00	0.38
Keratinocyte - oral, donor1	11251-116E9	21.80	3.29	3.63	0.34	0.00	0.23	0.00	0.00	0.45
Keratocytes, donor1	11527-119I6	18.22	3.44	3.09	0.00	0.34	0.00	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	9.37	1.17	2.34	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	12.05	5.73	3.36	0.20	0.20	0.20	0.00	0.00	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	57.15	13.19	4.40	0.00	0.00	2.20	0.00	2.20	4.40
Lens Epithelial Cells, donor1	11529-119I8	14.02	4.31	5.39	1.08	0.00	0.00	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	9.23	5.77	3.69	0.00	0.58	0.35	0.12	0.12	0.69
Lens Epithelial Cells, donor3	11690-122I7	17.36	3.53	2.93	0.61	0.71	0.20	0.00	0.00	0.50
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	11.50	1.90	1.54	0.00	0.12	0.12	0.00	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	7.26	3.07	0.28	0.00	0.56	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	10.23	1.42	1.10	0.00	0.00	0.16	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	7.53	0.54	0.00	0.00	0.54	0.54	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	8.51	0.95	0.63	0.32	0.00	0.00	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	5.28	1.29	0.75	0.00	0.00	0.00	0.00	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	6.57	2.05	1.64	0.00	0.00	0.00	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	2.53	1.26	0.00	0.00	0.25	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	6.47	1.55	0.56	0.00	0.00	0.14	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	8.70	1.98	0.40	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	5.82	2.13	1.16	0.19	0.19	0.00	0.19	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	5.00	0.74	0.56	0.00	0.19	0.19	0.00	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	10.10	3.48	1.74	0.00	0.00	0.35	0.35	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	5.49	1.67	0.95	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	6.18	1.79	0.41	0.27	0.14	0.00	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	10.47	1.85	2.77	0.31	0.31	0.00	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	2.81	1.56	0.62	0.31	0.00	0.00	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	6.40	0.91	0.91	0.37	0.18	0.37	0.18	0.00	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	6.25	1.65	0.00	0.33	0.00	0.33	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	3.81	1.17	0.59	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	3.73	0.75	0.75	0.25	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	10.18	2.91	0.00	0.00	0.00	0.00	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	7.27	0.81	0.54	0.27	0.27	0.54	0.00	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	9.84	1.51	0.76	0.30	0.15	0.00	0.00	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	6.74	0.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	7.75	2.51	0.42	0.21	0.63	0.63	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	6.92	2.41	0.15	0.15	0.15	0.15	0.00	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	10.32	1.38	0.00	0.69	0.69	0.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	9.22	2.07	0.94	0.38	0.19	0.19	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	7.32	0.95	0.32	0.21	0.21	0.11	0.11	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	8.24	2.42	0.97	0.00	0.00	0.00	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	2.98	0.66	0.33	0.66	0.00	0.00	0.66	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	5.20	1.49	0.00	0.25	0.12	0.00	0.12	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	11.48	2.96	1.48	0.00	0.00	0.00	0.37	0.00	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	8.40	2.96	0.25	0.00	0.25	0.49	0.00	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	5.91	1.37	0.00	0.14	0.00	0.00	0.00	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	10.29	2.25	0.00	0.32	0.32	0.00	0.96	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	7.91	3.35	0.61	0.30	0.00	0.00	0.91	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	11.62	2.10	0.70	0.42	0.00	0.28	0.00	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	8.53	1.78	2.13	0.36	0.00	0.00	0.71	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	3.88	2.91	0.00	0.00	0.00	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	2.65	0.93	0.00	0.00	0.00	0.00	0.00	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	5.73	1.79	0.36	0.00	0.36	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	8.17	0.65	0.65	0.00	1.31	0.00	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4.47	0.71	0.47	0.24	0.24	0.00	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	10.27	1.49	1.36	0.25	0.00	0.00	0.12	0.12	0.50
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	5.12	1.54	0.77	0.00	0.00	0.00	0.00	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.06	2.39	0.60	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	4.53	9.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	11.51	0.77	1.53	0.77	0.00	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	4.45	3.71	0.74	0.74	0.00	0.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	7.62	1.27	1.27	0.85	0.00	0.00	0.42	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	13.36	2.81	3.52	0.70	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	4.67	1.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	5.67	0.52	1.55	0.52	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	8.33	2.38	3.57	1.19	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	9.95	0.90	1.58	0.90	0.23	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	5.53	2.91	2.33	0.29	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	10.35	2.25	1.80	0.45	0.00	0.45	0.00	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	10.43	2.17	2.71	0.68	0.14	0.41	0.00	0.27	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	7.70	3.59	0.00	0.51	0.00	0.00	0.51	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	9.88	1.06	1.76	0.35	0.71	0.00	0.35	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	8.66	2.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	6.11	4.08	1.53	2.04	1.02	0.00	1.02	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	11.21	2.93	2.13	1.07	0.00	0.53	0.00	0.00	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	9.64	1.89	1.13	0.57	0.00	0.19	0.94	0.19	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	9.20	1.23	1.84	3.68	1.23	0.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	14.68	0.82	0.82	0.82	0.82	0.00	0.00	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	10.62	3.75	0.83	1.46	0.42	0.00	0.42	0.21	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	8.13	3.08	1.68	1.68	0.00	0.56	0.28	0.28	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	9.27	2.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	9.58	3.19	2.03	1.16	0.00	0.29	0.87	0.58	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	11.06	4.48	1.20	0.60	0.30	0.00	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	9.41	5.53	1.66	0.00	0.00	0.00	0.00	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	10.96	5.30	0.71	0.35	0.00	0.00	0.35	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	10.33	2.95	2.21	1.11	0.37	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	9.21	2.30	3.45	1.15	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	15.35	4.99	1.54	0.38	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	10.19	2.83	1.70	1.13	0.00	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	11.49	2.46	2.46	0.00	0.82	2.46	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	7.23	4.97	1.36	1.36	0.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	8.62	2.87	0.72	0.00	1.44	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	11.95	3.73	2.99	0.75	0.75	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	13.38	2.23	2.23	1.11	0.74	0.74	0.00	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	6.03	4.31	0.43	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	10.28	1.71	1.71	0.00	0.00	0.00	0.00	2.57	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	8.00	3.33	0.67	0.67	1.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	6.03	1.81	0.00	1.21	0.00	1.21	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	12.80	2.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	5.50	2.41	1.03	1.37	0.00	0.00	0.34	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	7.51	1.61	2.68	0.54	0.00	0.00	0.00	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	10.10	2.69	0.67	0.67	0.00	0.00	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	11.11	4.44	0.37	1.48	0.37	0.74	0.00	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	3.49	3.49	3.49	1.16	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	3.17	3.17	1.06	2.12	0.00	0.00	0.00	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	8.80	1.60	0.80	0.00	0.00	0.40	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	8.72	5.09	0.73	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	10.73	2.30	2.30	0.00	0.00	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	8.88	2.47	1.97	0.00	0.00	0.49	0.00	0.00	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	5.65	0.00	0.94	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	11.56	1.51	2.51	1.01	0.00	0.00	0.00	1.01	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	10.36	1.80	1.80	0.45	0.00	0.45	0.00	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	8.61	1.72	1.72	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	12.91	4.01	1.78	0.89	0.00	0.00	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	11.34	2.35	1.56	0.78	0.39	0.39	0.00	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	8.58	2.64	0.00	0.00	0.66	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	20.24	2.59	2.59	0.00	1.04	0.00	0.00	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	13.13	2.63	1.75	1.75	0.44	0.88	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	10.06	2.24	3.35	0.00	0.56	0.56	0.00	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	9.72	2.65	1.77	1.32	0.44	0.44	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	10.80	3.09	1.16	0.77	0.00	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	10.63	1.52	1.52	0.51	0.00	0.00	0.00	0.00	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	10.57	6.25	1.44	0.00	0.48	0.00	0.00	0.00	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	9.94	5.57	1.19	0.80	0.00	0.00	0.80	0.40	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	9.72	5.47	0.00	0.61	0.00	1.22	0.00	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	8.99	1.38	0.69	1.38	0.69	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	8.74	4.18	1.14	0.00	0.38	0.00	0.00	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	9.81	3.61	1.03	0.00	0.00	0.00	0.52	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	10.28	3.63	0.00	1.81	1.21	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	9.82	3.17	1.90	0.95	0.63	0.00	0.00	0.95	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	8.00	2.13	0.00	0.00	0.53	0.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	6.32	3.45	1.72	0.57	0.00	0.00	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	8.74	5.66	3.09	1.54	0.51	0.00	0.00	0.51	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	9.90	1.41	1.41	0.71	0.71	0.00	0.00	1.41	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	7.38	3.40	0.00	0.57	0.00	0.00	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	11.23	4.58	0.83	0.00	0.00	0.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	11.75	3.92	0.78	2.35	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	8.77	2.51	1.67	0.42	0.84	0.00	0.00	0.84	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	7.43	5.11	1.86	0.46	0.46	0.00	0.00	0.93	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	11.37	7.36	1.34	0.67	0.00	0.67	0.00	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	11.76	2.14	1.60	1.60	0.53	0.53	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	9.29	7.27	2.02	0.40	0.40	0.81	0.00	0.81	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	3.67	7.34	0.92	0.92	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	6.22	4.45	0.89	1.78	0.00	0.89	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	13.68	3.99	0.57	0.57	0.57	1.71	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	9.97	5.37	0.77	1.53	0.77	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	8.75	2.19	0.55	0.55	0.55	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	9.80	3.56	2.23	0.89	0.45	0.00	0.00	0.89	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	12.22	4.94	2.08	1.30	1.04	0.26	0.00	0.00	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	7.29	3.98	0.00	0.00	0.66	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	12.47	8.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	18.69	2.51	5.01	0.23	0.23	0.23	0.23	0.46	0.68
Macrophage - monocyte derived, donor2	11313-117C8	8.81	17.98	0.92	0.73	1.47	1.47	0.55	2.57	0.18
Macrophage - monocyte derived, donor3	11389-118C3	15.07	9.96	3.41	0.39	0.92	0.66	0.26	0.92	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	8.50	2.66	1.59	0.00	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	12.20	2.69	1.27	0.32	0.16	0.63	0.00	0.00	0.16
Mallassez-derived cells, donor3	11930-125I4	11.40	1.39	1.81	0.28	0.28	0.00	0.28	0.00	0.14
Mammary Epithelial Cell, donor1	11273-116H4	18.04	7.67	3.19	0.80	0.70	0.60	0.00	0.10	0.00
Mammary Epithelial Cell, donor2	11350-117G9	22.87	4.05	1.45	0.58	1.16	0.87	0.29	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	9.48	0.75	0.75	0.00	0.25	0.25	0.00	0.25	0.25
Mast cell - stimulated, donor1	11487-119E2	18.30	404.73	2.03	8.14	10.85	10.17	0.00	23.05	0.68
Mast cell, donor1	11563-120D6	44.34	31.25	3.14	5.95	2.16	2.38	0.65	2.92	1.51
Mast cell, donor2	11565-120D8	93.31	30.01	10.40	5.35	2.67	2.67	0.59	9.81	4.16
Mast cell, donor3	11566-120D9	111.44	27.01	16.21	2.93	6.08	1.58	0.45	7.88	5.18
Mast cell, donor4	11567-120E1	92.01	25.53	14.71	2.48	4.25	1.95	1.42	6.91	3.19
Mast cell, expanded and stimulated, donor5	11940-126A5	30.05	30.27	3.99	3.55	3.33	2.99	0.55	2.99	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	7.00	97.47	1.17	1.75	5.84	1.75	0.00	4.67	0.00
Mast cell, expanded, donor5	11939-126A4	38.89	8.49	3.79	0.23	0.57	0.23	0.69	0.46	0.80
Mast cell, expanded, donor8	11941-126A6	32.64	11.88	2.34	2.85	1.34	0.67	0.67	1.00	0.33
Melanocyte - dark, donor1	11502-119F8	12.64	2.79	2.49	0.00	0.30	0.00	0.00	0.10	0.50
Melanocyte - dark, donor2	11582-120F7	9.00	2.08	0.69	0.00	0.00	0.00	0.00	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	43.54	13.62	5.00	1.74	1.52	0.43	0.14	0.22	1.67
Melanocyte - light, donor1	11274-116H5	15.98	4.70	0.71	0.47	0.00	0.00	0.00	0.00	0.47
Melanocyte - light, donor2	11351-117H1	10.24	2.05	1.36	0.68	0.68	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	8.67	1.73	1.73	0.00	0.00	0.00	0.00	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	21.76	3.64	2.29	0.62	0.42	0.21	0.10	0.10	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	18.56	6.45	1.61	1.34	0.81	0.81	0.00	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	10.71	1.07	1.87	0.27	0.00	0.27	0.00	0.00	0.27
Meningeal Cells, donor1	11493-119E8	21.71	2.73	2.36	0.00	0.62	0.99	0.00	0.25	0.12
Meningeal Cells, donor2	11573-120E7	7.92	1.32	1.32	0.44	0.88	0.88	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	27.06	6.85	3.26	0.49	1.22	0.82	0.16	0.08	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	16.25	5.99	2.00	1.14	0.86	0.57	0.29	0.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	9.56	6.64	1.81	1.41	0.91	0.70	0.00	0.50	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	2.63	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	3.92	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	22.25	2.87	0.00	0.00	0.00	0.00	0.00	0.00	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	10.80	3.18	1.69	0.85	0.64	0.42	0.00	0.00	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	9.05	2.01	2.01	1.01	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	10.11	1.98	0.66	0.00	0.66	0.00	0.00	0.22	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	8.77	4.38	2.92	0.00	0.00	0.00	0.00	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	8.18	1.84	0.61	0.20	0.20	0.20	0.20	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	5.96	2.49	1.52	0.14	0.42	0.42	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5.58	0.74	0.37	0.37	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	11.05	3.29	1.97	0.00	0.13	0.00	0.13	0.00	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	5.34	0.30	0.89	0.00	0.30	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	6.40	1.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	24.81	6.03	3.54	0.35	0.35	0.35	0.35	0.35	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	8.13	3.13	1.88	0.94	0.00	0.00	0.00	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	20.32	0.73	2.18	0.73	0.00	0.00	0.00	0.00	2.18
Mesothelial Cells, donor1	11247-116E5	8.49	2.92	1.59	1.06	0.00	0.27	0.00	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	10.51	2.00	2.00	0.50	0.00	0.00	0.00	0.00	0.50
Mesothelial Cells, donor3	11402-118D7	8.96	2.60	3.25	0.65	0.29	0.22	0.29	0.22	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	37.81	9.45	4.05	0.00	1.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	13.05	10.84	2.71	0.99	1.48	0.25	0.00	0.49	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	10.60	10.60	1.47	1.18	0.59	0.88	0.00	0.59	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	3.46	3.46	0.00	0.00	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	10.85	5.27	2.79	0.93	0.93	0.31	0.00	0.31	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	9.13	12.24	1.66	1.04	0.41	0.41	0.00	1.04	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	9.26	4.63	4.63	0.00	2.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	8.01	6.76	2.00	0.50	1.00	0.25	0.00	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	8.84	7.45	1.40	1.86	0.47	0.93	0.00	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	10.57	11.58	1.42	0.61	1.02	0.61	0.00	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	7.13	9.50	0.79	0.79	1.98	0.00	0.00	1.19	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	17.10	0.00	0.00	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	7.96	2.65	0.88	0.88	0.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	2.28	9.12	0.76	1.14	0.00	0.76	0.00	0.76	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	25.00	2.63	2.63	0.00	1.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	4.24	4.67	0.85	0.42	1.49	0.21	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	14.73	12.89	0.00	0.92	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	4.47	3.58	0.89	0.89	0.30	0.00	0.00	0.00	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	10.06	3.35	0.00	3.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	7.03	6.77	1.25	0.50	0.50	0.50	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	6.65	8.32	0.24	0.95	1.19	1.43	0.00	0.95	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	10.50	1.66	3.32	0.55	0.55	0.55	0.00	0.55	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	5.07	5.99	1.61	0.23	0.46	0.23	0.00	0.46	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	6.52	7.15	0.00	0.84	0.84	1.05	0.00	1.05	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	5.30	5.10	0.82	0.20	0.61	0.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	5.36	4.72	0.64	0.64	1.07	0.43	0.21	0.43	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	5.11	9.78	1.11	0.89	1.33	0.67	0.00	0.67	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	5.04	6.13	0.44	0.00	0.44	0.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	4.56	8.11	1.01	0.51	1.01	0.51	0.00	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	16.57	3.31	1.66	0.00	0.00	0.00	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	6.25	6.25	0.54	0.00	0.27	0.00	0.27	0.82	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	5.29	7.94	0.88	0.88	0.29	0.29	0.00	0.88	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	15.26	2.18	0.00	0.00	1.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	3.84	3.84	0.48	0.48	1.44	0.48	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	4.80	5.20	0.80	0.40	0.00	0.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	20.57	4.11	1.37	0.00	0.00	0.00	0.00	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	4.00	2.00	1.00	0.00	1.00	0.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	2.04	6.12	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	9.63	5.26	1.31	0.88	0.88	0.44	0.44	0.88	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	13.24	9.93	1.10	0.00	1.10	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	22.41	3.84	5.12	0.64	0.64	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	12.40	4.46	0.50	0.50	1.49	0.25	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	11.13	11.13	2.78	0.70	0.70	0.00	0.00	1.39	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	35.36	4.42	6.63	0.00	0.00	2.21	0.00	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	12.65	5.13	3.76	0.00	0.00	0.34	0.00	0.00	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	10.50	8.31	1.31	2.19	0.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	20.95	7.10	3.91	1.07	0.71	0.00	0.00	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	13.47	6.73	2.24	0.84	0.28	0.00	0.28	0.00	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	9.98	11.22	0.83	0.83	1.25	0.83	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	26.22	4.08	3.50	1.17	0.58	0.00	0.00	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	9.05	3.32	1.81	0.90	0.30	0.00	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	15.44	9.60	1.25	0.42	1.25	0.83	0.00	0.83	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	79.41	0.00	7.22	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	13.85	2.77	3.69	1.85	0.92	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	15.37	7.97	1.14	1.71	1.71	0.57	0.00	1.14	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	13.68	4.70	1.38	0.28	0.14	0.00	0.00	0.14	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	10.11	3.89	1.81	0.26	0.52	0.26	0.00	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	15.01	7.29	1.72	1.29	0.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	22.23	1.91	2.54	0.00	0.00	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	10.41	5.07	1.33	0.27	0.27	0.27	0.27	0.27	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	12.87	8.08	1.50	1.50	1.20	1.20	0.00	0.30	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	10.31	3.81	2.54	0.14	0.00	0.00	0.14	0.14	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	9.24	2.87	0.64	0.00	0.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	13.05	10.39	1.77	0.66	0.66	0.66	0.22	0.44	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	13.65	1.90	1.14	1.14	0.38	0.00	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	11.36	3.69	0.57	0.28	0.28	0.00	0.00	0.85	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	10.82	6.39	1.23	0.98	0.98	0.00	0.49	0.49	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	12.38	3.26	1.96	0.00	0.65	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	12.94	1.76	2.35	0.59	0.88	0.29	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	12.97	6.92	1.44	1.15	1.44	0.86	0.00	0.29	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	14.43	3.30	2.06	0.00	0.82	0.00	0.00	1.24	2.47
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	14.59	5.66	1.19	0.00	0.30	0.00	0.00	0.30	0.89
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	0.00	3.77	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	5.35	5.35	0.00	0.00	1.78	0.00	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	9.53	2.63	3.61	0.33	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	6.31	2.10	1.05	1.05	1.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	9.69	2.77	1.19	0.20	0.40	0.20	0.20	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	14.90	12.11	2.79	0.00	0.00	1.86	0.00	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	9.39	5.26	2.63	0.75	1.88	0.00	0.38	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	9.59	4.53	0.53	0.27	1.07	0.27	0.00	0.27	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	13.12	2.71	2.15	0.57	0.34	0.23	0.00	0.00	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	5.89	0.74	0.74	1.47	0.74	0.00	0.00	1.47	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	8.79	1.83	0.37	0.00	0.00	0.00	0.00	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	15.56	6.22	0.00	0.00	1.56	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	21.91	11.76	1.60	1.60	1.60	0.53	0.00	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	3.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	7.07	2.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	9.70	6.75	0.84	0.84	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	20.43	10.90	2.72	2.72	0.00	1.36	0.00	4.09	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	11.44	10.17	1.27	0.64	0.00	0.64	0.00	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	21.06	9.72	0.00	1.62	0.00	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	13.59	12.08	1.51	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	51.39	22.84	17.13	11.42	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	9.79	45.67	6.52	0.00	0.00	0.00	6.52	9.79	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	4.75	0.00	0.00	0.00	0.00	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	37.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	14.22	5.17	1.72	0.43	0.65	0.65	0.22	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	5.75	4.18	1.57	0.52	0.00	1.05	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	4.67	4.67	0.67	2.00	0.00	1.33	0.67	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	7.93	4.59	1.67	1.25	1.25	1.25	0.42	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	15.02	7.23	3.23	2.09	1.90	1.14	0.00	0.38	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	22.34	20.75	4.79	0.00	1.60	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	2.72	2.04	0.00	0.68	0.68	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	27.56	11.03	7.35	0.00	3.68	1.84	7.35	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	1.26	1.26	0.00	0.42	0.00	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	3.72	3.02	0.93	0.70	1.39	0.46	0.00	0.46	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	2.43	2.97	0.00	0.27	0.27	0.27	0.54	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	11.35	4.20	0.84	0.42	0.84	0.00	0.21	0.00	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	55.67	11.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	1.49	3.47	0.99	0.00	0.00	0.00	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	4.06	2.71	0.54	0.27	0.00	0.27	0.00	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	1.13	3.40	0.00	0.45	0.23	0.00	0.23	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	2.29	3.27	0.82	0.33	0.33	0.16	0.00	0.00	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	6.38	3.28	1.09	0.73	0.36	0.91	0.36	0.00	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	2.65	1.06	0.53	0.53	0.00	0.53	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	2.40	3.60	0.00	0.00	1.80	0.00	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	4.59	2.95	2.30	0.33	0.98	0.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	0.65	1.14	0.00	0.00	0.33	0.00	0.00	0.00	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	8.11	2.82	1.41	0.35	0.71	0.00	0.18	0.00	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	2.11	2.81	0.00	0.00	0.00	0.00	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	1.84	2.76	0.00	0.00	0.00	0.00	0.46	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	2.57	2.57	0.00	0.32	0.32	0.32	0.00	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	3.45	1.72	1.72	0.34	0.34	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	25.28	7.59	17.70	2.53	2.53	0.00	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	9.80	2.67	2.01	0.22	0.89	0.22	0.22	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	2.96	2.12	0.42	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	1.90	2.37	0.47	0.47	0.24	0.00	0.00	0.00	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	1.29	2.15	0.43	0.43	0.43	0.86	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	27.08	9.03	9.03	0.00	9.03	9.03	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	2.67	2.67	0.00	0.00	0.33	0.67	0.00	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	7.66	1.80	1.80	0.90	1.35	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	1.59	5.16	0.00	0.40	0.00	0.40	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	2.79	0.93	0.93	0.00	0.00	0.93	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	5.30	3.41	1.14	0.76	0.76	0.38	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	2.93	2.61	0.33	0.98	0.33	0.00	0.00	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	3.92	3.49	0.00	0.00	0.44	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	6.78	6.78	0.45	0.00	0.45	0.90	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	0.00	2.65	0.00	0.88	0.00	0.88	1.76	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	0.66	1.99	0.66	0.00	0.66	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	1.49	2.48	0.50	0.00	0.00	0.50	0.00	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	0.38	2.68	0.77	0.00	0.38	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	3.93	3.93	0.30	0.30	0.60	0.00	0.30	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	8.18	4.86	2.21	0.00	0.00	0.44	0.00	0.44	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	1.36	2.03	0.68	0.00	1.36	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	15.33	10.22	0.00	0.00	0.00	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	3.66	2.44	0.61	0.00	0.61	0.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	3.15	5.67	0.00	0.31	0.31	0.00	0.31	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	0.91	3.93	0.30	0.00	0.00	0.00	0.61	0.61	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	0.79	3.96	0.00	0.00	0.00	0.00	0.79	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	11.34	3.40	3.40	0.00	0.00	1.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	10.12	5.06	5.06	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	10.31	3.98	1.86	0.87	0.37	0.99	0.25	0.12	0.25
Myoblast, donor2	11322-117D8	14.38	4.41	2.30	0.19	1.15	0.58	0.00	0.00	0.00
Myoblast, donor3	11398-118D3	23.54	9.25	2.69	3.20	1.18	0.67	0.50	0.84	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	137.03	17.07	8.46	5.25	0.88	0.44	1.61	1.31	3.06
Natural Killer Cells, donor1	11230-116C6	39.36	3.38	1.85	1.85	0.31	0.00	1.54	0.62	0.92
Natural Killer Cells, donor2	11311-117C6	31.66	2.41	3.92	4.22	0.30	0.00	0.60	0.00	1.21
Natural Killer Cells, donor3	11387-118C1	31.66	5.15	2.76	1.84	0.55	0.18	0.74	0.55	0.74
Neural stem cells, donor1	11275-116H6	32.66	14.15	5.81	2.54	3.27	2.18	0.00	0.00	0.73
Neural stem cells, donor2	11352-117H2	19.26	15.41	5.78	3.85	0.00	0.00	0.00	0.00	1.93
Neurons, donor1	11494-119E9	18.21	6.83	6.83	1.14	0.00	1.14	0.00	0.00	0.00
Neurons, donor2	11574-120E8	10.57	3.08	3.30	0.00	0.22	0.22	0.66	0.00	0.44
Neurons, donor3	11655-122E8	9.04	10.69	2.47	1.64	1.64	4.11	0.82	0.82	0.00
Neutrophils, donor1	11233-116C9	14.85	0.00	1.86	0.93	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	11.60	0.00	5.80	0.00	0.00	0.00	0.00	0.00	2.90
Neutrophils, donor3	11390-118C4	22.60	1.83	6.11	0.00	0.00	0.00	0.00	0.61	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	11.64	4.75	2.49	0.59	0.83	0.24	0.00	0.12	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	3.26	1.63	1.30	0.00	0.65	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	7.02	2.61	1.00	0.40	0.00	0.40	0.00	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	4.54	2.75	0.55	0.28	0.00	0.00	0.00	0.00	0.00
Olfactory epithelial cells, donor2	11934-125I8	6.08	3.62	0.87	0.43	0.29	0.58	0.00	0.00	0.14
Olfactory epithelial cells, donor3	11935-125I9	4.88	2.50	0.91	0.23	0.45	0.11	0.34	0.00	0.00
Olfactory epithelial cells, donor4	11936-126A1	7.50	2.92	1.27	0.19	0.00	0.10	0.00	0.10	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	13.84	1.81	1.20	0.60	1.20	1.20	0.00	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	3.62	2.77	0.21	0.00	0.21	0.64	0.00	0.21	0.21
Osteoblast - differentiated, donor2	11353-117H3	1.14	2.29	2.29	0.00	0.00	0.00	0.00	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	5.59	2.48	1.24	0.62	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	5.47	1.17	0.20	0.00	0.39	0.20	0.00	0.20	0.20
Osteoblast, donor2	11354-117H4	14.75	6.32	3.51	1.40	1.40	0.70	0.00	0.00	0.70
Osteoblast, donor3	11426-118G4	15.82	6.40	3.02	0.71	0.18	0.18	0.00	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	10.45	3.45	2.02	0.67	0.42	0.34	0.34	0.08	0.17
Pericytes, donor1	11491-119E6	3.56	1.11	1.11	0.33	0.11	0.11	0.00	0.00	0.11
Pericytes, donor2	11571-120E5	6.34	0.68	0.91	0.45	0.23	0.00	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	6.10	1.83	1.02	0.00	0.20	0.00	0.00	0.00	0.00
Perineurial Cells, donor1	11499-119F5	12.88	3.84	2.37	0.23	0.90	0.79	0.11	0.00	0.57
Perineurial Cells, donor2	11579-120F4	16.75	2.02	2.48	0.46	0.28	0.09	0.00	0.18	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	37.29	2.55	2.55	1.59	0.00	0.00	0.96	0.00	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	21.06	2.94	2.94	0.49	0.00	0.00	0.00	0.24	1.47
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	22.00	3.49	3.24	1.68	0.13	0.26	0.65	0.00	1.04
Placental Epithelial Cells, donor1	11278-116H9	4.30	0.96	0.24	0.48	0.48	0.00	0.00	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	6.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	3.34	0.98	0.39	0.00	0.20	0.00	0.00	0.00	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	6.01	8.23	1.58	1.90	0.32	0.63	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	11.44	8.82	1.69	2.25	0.38	1.31	0.00	0.19	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	8.75	3.26	1.44	1.17	0.26	0.39	0.78	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	15.31	7.43	3.38	2.03	0.68	0.45	0.23	0.45	1.13
Preadipocyte - omental, donor1	11468-119C1	11.19	5.65	1.17	1.39	0.21	0.85	0.21	0.11	0.64
Preadipocyte - omental, donor2	11329-117E6	15.71	9.17	1.75	3.06	0.44	0.00	0.00	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	17.76	9.74	1.86	2.15	1.00	0.29	0.29	0.00	0.29
Preadipocyte - perirenal, donor1	11469-119C2	4.92	2.95	0.00	0.00	0.00	0.00	0.00	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	11.36	6.14	0.61	1.23	0.31	0.92	0.00	0.00	1.23
Preadipocyte - subcutaneous, donor2	11356-117H6	27.45	6.73	5.49	0.71	0.53	1.06	0.00	0.00	0.89
Preadipocyte - subcutaneous, donor3	11428-118G6	19.24	8.00	3.75	1.02	0.68	1.19	0.00	0.51	0.34
Preadipocyte - visceral, donor1	11280-116I2	27.85	6.89	2.61	0.93	1.02	0.37	0.19	0.09	0.47
Preadipocyte - visceral, donor2	11357-117H7	21.17	3.68	1.38	0.46	0.00	0.00	0.00	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	14.73	2.72	1.36	1.36	0.73	0.21	0.00	0.21	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	40.43	13.58	5.58	1.51	1.81	1.81	0.91	0.00	0.60
Prostate Epithelial Cells, donor2	11331-117E8	8.12	1.49	2.03	0.54	0.14	0.14	0.00	0.00	0.00
Prostate Epithelial Cells, donor3	11404-118D9	13.04	3.37	3.80	0.24	0.18	0.06	0.00	0.06	0.55
Prostate Stromal Cells, donor1	11254-116F3	13.55	3.19	1.82	0.46	0.57	0.11	0.11	0.23	0.23
Prostate Stromal Cells, donor2	11332-117E9	17.21	3.59	2.33	1.08	0.36	0.54	0.36	0.36	0.54
Prostate Stromal Cells, donor3	11405-118E1	8.34	2.40	2.09	0.21	0.42	0.31	0.21	0.10	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	10.58	0.36	1.46	0.00	0.00	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	16.08	2.36	1.87	0.07	0.14	0.07	0.07	0.28	0.42
Renal Epithelial Cells, donor1	11517-119H5	13.19	1.52	0.51	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	10.67	0.71	0.71	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	18.63	4.87	2.22	0.64	0.21	0.32	0.32	0.00	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	8.17	0.00	0.68	0.00	0.00	0.68	0.00	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	11.05	2.02	0.94	0.00	0.00	0.13	0.00	0.13	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	23.53	3.33	2.22	0.44	0.22	0.00	0.22	0.00	1.55
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.32	0.00	2.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	8.80	1.10	1.10	1.10	0.44	0.00	0.00	0.00	0.22
Renal Mesangial Cells, donor2	11598-120H5	10.03	1.25	1.88	0.63	0.00	1.25	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	5.55	1.11	0.83	0.00	0.00	0.28	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	21.21	1.88	1.88	0.27	0.00	0.27	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	8.43	0.84	1.27	0.42	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	16.20	1.54	2.51	0.19	0.58	0.58	0.00	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	7.52	1.81	4.67	0.00	0.26	0.26	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	13.64	0.85	4.55	0.85	0.28	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	7.20	2.06	0.00	1.03	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	8.03	2.76	0.25	0.00	0.00	0.25	0.00	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	11.89	2.14	3.88	0.27	0.27	0.13	0.40	0.00	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	33.06	14.29	1.79	0.89	1.79	2.68	1.79	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	12.11	9.36	1.65	0.55	2.20	1.65	4.40	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	33.64	16.24	5.22	0.00	2.32	1.16	1.16	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	25.61	8.97	4.55	0.39	1.82	1.56	0.13	0.26	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	21.35	9.73	4.47	0.70	1.09	1.19	0.40	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	25.88	15.06	4.35	1.12	2.68	1.78	0.78	0.00	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	27.79	10.92	6.33	0.37	1.98	1.36	0.37	0.00	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	18.88	10.61	2.91	0.47	2.56	1.63	0.12	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	26.12	16.64	6.01	0.23	1.16	2.31	1.16	0.00	1.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	21.36	8.21	2.74	0.41	1.64	1.51	0.41	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	22.39	10.14	3.03	1.21	1.36	1.06	0.76	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	25.62	11.11	4.48	0.36	2.69	2.69	0.90	0.00	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	19.08	9.32	3.16	0.14	2.87	1.72	0.14	0.14	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	20.60	8.16	4.94	0.54	1.72	2.47	0.43	0.00	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	15.05	9.51	3.98	0.89	1.33	2.21	0.00	0.00	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	21.03	7.07	3.06	0.38	2.10	0.96	0.57	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	21.80	9.60	4.10	0.37	1.40	1.02	0.19	0.00	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	31.00	17.29	4.13	0.19	3.19	1.69	1.13	0.19	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	24.95	10.22	4.11	0.80	2.12	1.33	0.00	0.40	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	23.17	10.61	5.06	0.49	1.46	1.65	0.29	0.10	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	22.53	13.56	5.35	0.95	1.91	1.91	1.72	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	22.11	10.25	4.38	1.28	1.71	1.28	0.11	0.21	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	21.30	11.49	2.52	0.56	2.80	1.40	1.12	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	21.36	13.67	3.25	0.68	2.05	1.03	0.51	0.00	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	26.62	11.49	2.73	1.09	3.28	1.82	0.18	0.18	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	18.27	11.28	3.68	0.86	1.72	0.98	0.49	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	24.45	15.98	3.49	1.61	1.21	1.75	0.81	0.13	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	19.34	11.79	2.12	1.18	2.83	0.94	0.00	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	22.02	11.11	2.38	0.40	1.98	0.60	1.19	0.60	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	24.79	12.39	3.51	0.47	2.34	0.47	1.87	0.00	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	22.81	10.16	3.53	1.66	2.49	1.45	0.21	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	21.01	15.71	2.65	0.66	2.21	0.88	0.44	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	23.19	14.00	4.80	1.67	2.30	2.30	0.63	0.00	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	23.96	13.32	4.58	2.29	2.56	0.67	0.27	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	23.84	14.13	5.45	1.02	2.72	0.68	0.51	0.51	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	27.38	16.58	4.24	0.58	1.54	2.31	0.96	0.00	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	19.43	9.97	3.44	1.03	2.58	0.69	0.52	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	19.89	13.85	3.70	1.37	2.33	1.65	0.27	0.41	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	25.61	12.64	3.94	0.99	1.97	1.64	0.82	0.00	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	17.55	7.16	3.24	0.34	2.73	0.51	0.34	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	18.05	13.17	2.96	0.44	1.78	1.92	0.59	0.15	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	17.86	11.20	5.06	0.80	2.40	1.33	1.33	0.00	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	20.33	9.40	3.32	0.55	1.66	0.69	0.00	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	23.57	11.91	5.24	1.43	1.19	1.67	1.43	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	29.02	14.71	5.04	1.01	1.61	2.82	1.81	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	21.10	8.85	2.64	1.32	1.22	0.75	0.09	0.09	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	25.85	14.32	3.49	1.05	3.84	1.75	1.40	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	27.20	14.20	2.72	2.12	1.21	0.91	0.60	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	21.17	8.81	1.71	1.22	1.84	1.71	0.37	0.00	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	55.02	27.95	6.70	2.47	4.66	3.06	4.22	0.15	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	31.64	12.17	2.43	0.61	2.43	3.65	1.83	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	18.39	10.25	3.01	1.51	0.60	0.90	0.90	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	25.79	12.67	4.52	1.36	1.36	1.58	0.90	0.23	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	35.94	20.37	3.89	1.80	1.50	2.40	0.90	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	23.85	11.22	2.95	1.18	2.13	0.59	0.24	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	31.16	13.66	1.71	1.71	1.71	1.07	1.49	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	44.47	18.63	7.81	1.80	1.80	1.20	1.20	0.00	1.20
Schwann Cells, donor1	11498-119F4	10.16	1.32	0.94	0.75	0.38	0.00	0.00	0.00	0.19
Schwann Cells, donor2	11578-120F3	17.01	3.40	3.40	3.40	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	8.11	4.16	1.75	0.44	0.44	0.00	0.00	0.00	0.44
Sebocyte, donor1	11220-116B5	9.86	0.55	2.74	0.55	0.00	0.00	0.00	0.00	0.55
Sebocyte, donor2	11301-117B5	8.27	0.46	0.46	0.46	0.46	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	5.98	2.89	1.24	0.00	0.00	0.21	0.00	0.00	0.21
Sertoli Cells, donor1	11255-116F4	14.91	3.31	0.00	0.00	0.00	0.00	0.00	0.00	1.66
Sertoli Cells, donor2	11333-117F1	8.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	10.21	4.49	1.67	0.44	0.62	0.00	0.26	0.09	0.44
Skeletal Muscle Cells, donor2	11358-117H8	0.72	0.72	0.72	0.00	0.00	0.00	0.00	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	10.87	0.00	0.00	0.84	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	18.22	3.14	3.61	0.47	1.10	0.47	0.31	0.31	0.16
Skeletal Muscle Cells, donor5	11455-119A6	13.38	3.12	2.38	1.34	0.59	0.15	0.15	0.00	0.15
Skeletal Muscle Cells, donor6	11459-119B1	21.39	5.69	2.00	0.77	0.92	0.31	0.31	0.00	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	11.34	3.40	1.39	0.63	0.63	0.76	0.38	0.00	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	11.42	2.85	2.00	0.29	0.43	0.57	0.29	0.00	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	26.09	7.84	2.78	0.89	0.89	0.69	0.20	0.30	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	10.03	4.04	2.53	0.59	0.17	0.51	0.17	0.00	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	5.07	0.72	2.90	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	5.64	3.03	1.79	0.83	0.55	0.14	0.00	0.14	0.28
Skin - palm, donor1	10286-104F7	24.17	2.69	2.69	0.00	2.69	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	6.92	1.87	0.86	0.58	0.14	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	17.99	0.82	2.45	0.00	0.82	0.00	3.27	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	10.13	1.30	0.52	0.39	0.13	0.26	0.00	0.00	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	13.07	3.61	1.39	0.56	0.56	0.00	0.14	0.00	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	19.13	2.67	2.11	0.98	0.14	0.00	0.14	0.14	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	35.73	1.90	4.86	0.42	0.21	0.00	2.33	0.21	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	21.51	3.67	2.85	1.05	0.37	0.15	0.07	0.00	0.90
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	6.79	1.54	1.54	0.00	0.62	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	7.34	0.89	0.67	0.22	0.00	0.22	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	11.17	4.70	4.11	0.00	1.18	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	6.41	5.52	1.33	0.88	0.44	0.88	0.00	0.00	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	11.42	2.76	1.18	0.39	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	30.90	4.64	3.09	0.77	0.00	0.00	0.00	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	3.00	1.00	2.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	11.18	1.46	2.40	0.27	0.13	0.13	0.00	0.00	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	11.53	3.32	1.55	0.66	0.44	0.66	0.22	0.00	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	13.32	4.10	1.92	1.41	0.64	0.38	0.00	0.00	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	8.79	2.93	2.60	0.00	0.00	0.65	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	8.27	3.54	1.18	1.18	0.59	0.30	0.00	0.30	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	7.40	1.57	1.42	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	7.16	1.14	1.14	0.00	0.33	0.00	0.00	0.16	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	9.44	3.35	1.83	0.30	0.30	0.00	0.00	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	10.61	2.27	1.26	0.00	0.00	0.51	0.00	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	5.72	1.43	1.43	0.00	0.48	0.00	0.00	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	8.70	1.62	0.74	0.15	0.74	0.00	0.00	0.15	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	7.32	0.86	1.51	0.00	0.00	0.43	0.22	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	10.39	1.78	1.68	0.10	0.21	0.10	0.21	0.00	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	8.66	1.70	1.08	0.46	0.15	0.31	0.00	0.15	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	11.86	3.23	1.08	0.00	0.00	0.00	0.00	1.08	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	10.16	0.90	1.49	1.20	0.00	0.00	0.30	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	5.46	0.68	2.05	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	5.10	2.04	1.10	0.08	0.24	0.24	0.24	0.16	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	10.87	4.83	1.61	1.31	0.70	0.20	0.00	0.30	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	15.25	3.87	2.28	1.14	0.23	0.00	0.46	0.68	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	6.04	2.42	0.00	2.42	0.00	0.00	0.00	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	32.06	5.83	4.50	1.59	1.32	0.26	0.26	0.26	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	9.19	1.86	1.86	0.67	0.53	0.27	0.00	0.13	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	9.27	2.38	2.00	0.88	0.25	0.00	0.00	0.13	0.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	4.57	2.79	1.52	0.00	0.25	0.00	0.00	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	20.66	10.10	3.92	3.32	1.96	0.90	0.00	0.60	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	7.50	2.25	1.50	0.75	0.75	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	14.21	19.38	1.29	2.58	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	6.51	5.58	1.40	2.33	0.93	0.47	0.47	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	17.17	3.53	2.02	0.00	0.00	0.00	0.00	1.01	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	5.33	2.19	1.57	0.94	0.31	0.00	0.31	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	4.13	1.18	0.29	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	20.99	4.08	2.42	0.75	0.67	0.42	0.25	0.25	0.75
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	2.80	2.80	1.40	0.00	0.93	0.00	0.00	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	10.36	1.30	0.43	0.14	0.00	0.14	0.00	0.14	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	9.43	3.57	2.04	0.51	0.51	0.00	0.00	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	8.09	0.94	0.94	0.19	0.19	0.00	0.00	0.19	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	16.21	3.35	2.52	0.14	0.28	0.14	0.14	0.14	0.84
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	9.13	1.51	1.17	0.34	0.17	0.17	0.08	0.00	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	0.48	0.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	9.05	1.96	1.47	0.24	0.24	0.24	0.00	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	11.05	15.47	1.10	3.09	2.43	1.99	0.22	1.55	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	11.12	4.39	0.29	0.29	0.29	0.59	0.29	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	4.66	2.14	1.36	0.00	0.00	0.39	0.39	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	4.50	0.26	0.26	0.00	0.53	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	2.60	0.37	0.00	0.37	0.37	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	5.03	0.36	1.44	0.00	0.00	0.72	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	8.23	1.99	0.57	0.57	0.00	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	10.63	2.76	0.39	0.39	0.79	0.00	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	3.56	2.03	1.27	0.00	0.00	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	2.40	1.20	0.80	0.00	0.80	0.00	0.40	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	2.93	1.25	1.25	0.42	0.00	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	5.04	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	9.43	11.11	1.35	0.84	1.68	0.50	0.00	0.34	0.34
Synoviocyte, donor2	11368-117I9	7.88	3.35	2.35	0.00	1.01	0.34	0.00	0.17	0.17
Synoviocyte, donor3	11440-118H9	4.92	2.23	1.34	0.22	0.45	0.00	0.00	0.22	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	12.51	2.14	1.43	0.00	0.36	0.36	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	1.98	1.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	6.02	1.62	0.69	0.00	0.23	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	10.75	1.72	1.36	0.14	0.29	0.00	0.07	0.07	0.43
Tracheal Epithelial Cells, donor2	11369-118A1	3.48	2.32	0.00	0.77	0.00	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	4.01	0.00	0.57	0.00	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	13.16	1.85	3.20	0.25	0.49	0.00	0.74	0.00	0.37
Urethra, donor2	10319-105A4	14.39	3.60	3.60	0.00	0.00	0.00	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	6.38	0.80	1.33	0.00	0.00	0.27	0.00	0.00	0.80
Urothelial Cells, donor2	11600-120H7	6.01	0.40	0.80	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	5.27	0.46	0.46	0.46	0.00	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	19.39	4.68	4.68	0.45	0.22	0.00	0.00	0.00	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	24.02	1.78	5.34	1.78	0.00	0.00	0.89	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	45.75	2.86	7.15	0.00	1.43	0.00	0.00	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	15.06	2.05	2.74	0.00	0.00	0.00	1.37	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	29.61	1.72	1.72	0.69	0.00	0.34	1.03	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	25.57	1.16	4.07	0.58	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	21.87	5.21	3.12	1.04	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	19.27	1.84	0.92	0.00	0.00	0.00	0.00	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	16.43	1.83	3.65	1.83	0.00	0.00	0.91	0.00	1.83
Wilms' tumor cell line:G-401	10809-111A8	22.33	9.38	7.90	0.86	0.99	2.10	0.25	0.12	0.99
Wilms' tumor cell line:HFWT	10597-108E3	13.20	11.44	2.64	0.00	0.00	0.00	1.76	0.00	1.76
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	12.57	0.84	6.14	0.28	0.28	0.00	0.00	0.00	0.28
achilles tendon, donor2	10292-104G4	12.40	6.20	0.00	4.13	2.07	0.00	10.33	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	67.56	4.33	0.76	1.27	0.25	0.00	1.78	0.76	1.78
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	94.26	1.86	7.66	0.70	0.23	0.23	0.93	0.00	1.86
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	414.41	2.61	21.96	4.39	0.47	0.00	0.24	0.12	6.41
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	101.50	6.80	5.44	6.26	0.54	0.27	0.82	0.00	1.36
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	25.30	2.53	1.69	0.28	0.28	0.00	0.00	0.28	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	30.88	5.50	1.90	4.65	1.06	0.21	0.00	1.06	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	34.30	3.81	2.18	0.27	0.27	0.00	1.09	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	31.29	0.00	2.64	0.44	0.00	0.44	0.44	0.44	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	28.18	1.63	2.45	0.82	0.00	0.00	0.41	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	54.75	1.55	6.60	0.78	0.39	0.00	0.78	0.00	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	40.11	2.76	2.21	0.18	0.55	0.37	0.18	0.00	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	66.31	3.90	15.60	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	33.93	22.54	1.39	5.11	1.16	1.16	0.46	0.93	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	45.05	2.85	3.11	1.04	0.78	0.52	1.04	0.00	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	39.45	1.75	4.68	1.46	1.17	0.00	0.88	0.00	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	28.35	3.25	4.18	1.86	0.00	0.46	0.46	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	37.01	3.29	2.06	1.65	0.41	0.00	0.00	0.00	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	27.63	4.30	2.15	1.84	0.31	0.31	0.31	0.31	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	51.21	9.81	6.83	4.27	0.00	0.43	1.28	2.13	1.71
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	68.24	7.89	6.37	4.55	0.61	0.00	0.00	1.21	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	72.93	8.42	5.78	5.54	0.24	0.72	0.96	0.96	0.96
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	31.18	2.23	0.67	0.00	0.45	0.00	0.67	0.00	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	31.02	16.34	3.00	3.34	3.00	3.00	0.00	1.33	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	35.31	0.00	3.72	1.86	0.00	0.00	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	27.50	1.88	0.38	1.51	0.38	0.38	0.38	0.00	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	37.51	20.06	8.29	2.18	1.31	0.44	0.87	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	110.59	7.50	13.12	3.75	0.00	0.00	0.00	0.00	3.75
adenocarcinoma cell line:IM95m	10796-110I4	22.84	1.41	3.77	0.24	0.47	0.24	0.00	0.00	0.47
adipose tissue, adult, pool1	10010-101C1	13.34	6.52	3.72	0.16	1.09	0.16	0.00	0.00	0.78
adipose, donor1	10184-103D4	22.87	5.28	8.80	1.76	0.59	0.59	1.76	0.00	1.17
adipose, donor2	10185-103D5	14.19	8.11	1.62	0.41	0.41	1.22	2.43	0.00	0.81
adipose, donor3	10186-103D6	10.07	4.90	3.81	0.54	0.27	1.09	0.54	0.00	0.27
adipose, donor4	10187-103D7	19.94	4.33	0.00	0.00	3.47	0.00	0.00	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	14.05	15.15	9.78	0.00	2.84	1.58	0.63	0.63	1.10
adrenal gland, adult, pool1	10081-102A9	3.64	0.00	3.64	3.64	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	61.63	7.34	6.14	1.60	0.80	0.27	0.93	0.67	0.93
alveolar cell carcinoma cell line:SW 1573	10708-109H6	28.58	5.72	2.86	0.36	0.36	1.43	0.36	0.00	1.43
amniotic membrane cells, donor1	12235-129G3	9.74	3.71	1.16	0.70	0.23	0.00	0.23	0.00	0.70
amniotic membrane cells, donor2	12236-129G4	9.13	3.04	3.38	0.68	0.00	0.00	0.34	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	6.48	3.54	3.54	0.00	0.88	0.29	0.00	0.00	0.59
amygdala - adult, donor10196	10167-103B5	7.11	8.30	0.00	0.00	1.19	1.19	2.37	0.00	1.19
amygdala, adult, donor10252	10151-102I7	13.99	15.82	4.26	1.01	1.01	0.61	0.81	0.00	0.20
amygdala, newborn, donor10223	10360-105E9	3.55	9.04	0.65	0.32	0.65	0.97	1.29	1.61	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	10.19	11.97	1.91	0.64	1.15	0.38	0.38	0.13	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	28.02	1.32	1.54	0.44	0.66	0.00	1.10	0.00	1.32
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	25.39	20.04	8.02	0.00	1.67	1.34	4.68	1.34	0.67
aorta, adult, pool1	10052-101G7	9.41	8.24	2.55	0.00	0.78	0.59	0.98	0.20	0.98
appendix, adult	10189-103D9	31.05	3.49	3.10	1.55	1.16	0.39	0.39	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	50.90	12.73	2.75	0.69	0.00	1.03	2.75	0.00	0.34
artery, adult	10190-103E1	8.15	13.59	1.36	0.00	1.36	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	22.60	13.33	3.91	0.58	0.72	1.88	0.58	0.14	0.43
b cell line:RPMI1788	10427-106D4	23.94	1.64	3.42	0.45	0.15	0.00	0.30	0.45	1.34
basal cell carcinoma cell line:TE 354.T	10702-109G9	9.71	1.94	1.66	0.55	0.00	0.55	0.28	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	21.24	3.87	2.08	0.79	0.40	0.50	0.20	0.30	0.50
bile duct carcinoma cell line:TFK-1	10496-107C1	10.54	4.35	3.51	0.17	0.67	0.17	0.50	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	25.72	5.59	0.56	2.24	2.24	0.56	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	14.34	4.45	4.67	0.00	0.65	0.33	0.54	0.00	0.43
blood, adult, pool1	10053-101G8	17.72	2.21	2.21	0.00	0.00	0.00	0.00	2.21	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	15.41	5.99	0.00	0.86	0.00	0.86	0.00	0.00	0.86
bone marrow, adult	10192-103E3	19.57	4.72	0.67	2.02	0.00	0.67	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	3.08	9.23	3.08	0.00	1.03	0.00	0.00	0.00	1.03
brain, adult, pool1	10012-101C3	8.46	12.81	2.00	0.33	1.45	1.34	0.33	0.00	0.00
brain, fetal, pool1	10085-102B4	10.69	5.34	5.34	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	15.53	2.64	4.29	0.33	0.00	0.00	0.99	0.00	1.32
breast carcinoma cell line:MDA-MB-453	10419-106C5	22.97	11.23	8.36	0.62	1.50	1.25	0.25	0.25	0.50
breast, adult, donor1	10080-102A8	6.94	5.05	3.16	0.00	0.00	0.00	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	19.18	2.03	4.83	0.00	0.13	0.38	0.64	0.00	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	18.24	9.28	5.26	0.31	0.31	0.31	0.31	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	6.45	2.76	2.30	0.00	0.69	0.00	0.92	0.69	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	26.39	7.75	2.91	0.97	1.94	1.45	1.45	0.24	0.73
carcinoid cell line:NCI-H1770	10703-109H1	29.62	1.41	6.58	0.47	0.00	0.00	1.88	0.47	0.47
carcinoid cell line:NCI-H727	10735-110B6	27.02	3.50	4.27	0.33	0.22	0.11	0.00	0.00	1.20
carcinoid cell line:SK-PN-DW	10719-109I8	17.75	0.63	1.27	1.27	0.32	0.32	0.95	0.00	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	33.80	5.59	1.60	0.53	0.00	0.80	1.06	0.53	0.80
caudate nucleus - adult, donor10196	10177-103C6	13.82	11.51	6.91	2.30	0.00	1.15	1.15	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	10.88	7.03	4.35	0.17	1.67	0.33	0.33	0.00	0.50
caudate nucleus, adult, donor10258	10379-105H1	1.53	3.82	0.00	0.00	1.53	0.76	0.76	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	7.69	5.49	3.30	0.73	0.37	0.37	0.73	0.73	0.00
cerebellum - adult, donor10196	10173-103C2	14.57	8.74	2.91	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	9.61	13.02	4.70	0.00	1.28	0.43	1.28	0.21	0.85
cerebellum, adult, pool1	10083-102B2	2.41	2.76	1.03	0.00	0.00	0.69	0.34	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	4.15	5.81	1.66	0.00	0.00	0.83	0.83	0.00	0.00
cerebral meninges, adult	10188-103D8	6.05	4.29	1.26	0.25	1.26	0.25	0.25	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	5.12	5.12	0.00	0.00	1.46	0.00	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	15.96	9.49	2.73	0.29	2.30	1.58	0.43	0.00	0.14
cervical cancer cell line:ME-180	10553-107I4	20.22	4.81	4.14	1.33	0.33	0.33	0.17	0.17	0.33
cervix, adult, pool1	10013-101C4	16.27	10.50	4.51	0.10	0.94	0.21	0.21	0.00	0.73
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	12.68	2.65	2.65	0.28	0.42	0.42	0.28	0.14	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	18.29	1.31	3.92	1.31	0.00	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	27.59	1.99	8.08	0.37	0.12	0.37	0.87	0.12	0.87
choriocarcinoma cell line:SCH	10785-110H2	7.89	4.68	4.07	0.00	0.00	0.62	0.00	0.00	1.11
choriocarcinoma cell line:T3M-3	10618-108G6	20.40	2.85	3.79	0.00	0.00	0.47	0.47	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	8.55	1.99	1.99	0.28	0.00	0.57	0.28	0.00	0.28
chorionic membrane cells, donor2	12239-129G7	15.51	3.18	4.67	0.89	0.30	0.10	0.10	0.10	0.50
chorionic membrane cells, donor3	12240-129G8	13.19	2.20	3.85	0.55	0.00	0.00	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	38.37	3.03	0.00	1.01	0.00	0.00	1.01	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	33.43	6.53	4.23	2.11	0.96	0.58	0.58	0.77	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	30.83	2.96	5.49	1.06	0.21	0.21	0.63	0.63	0.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	23.63	1.28	2.31	0.00	0.00	0.00	0.26	0.26	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	22.25	2.90	2.18	0.97	0.73	0.24	0.24	0.00	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	29.32	4.28	2.85	1.63	0.81	0.20	0.41	0.20	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	11.78	1.18	1.77	0.00	0.00	0.29	0.29	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	41.44	1.56	4.17	1.04	0.26	0.00	1.04	0.00	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	14.86	4.57	3.89	0.00	0.46	0.00	0.69	0.00	0.69
clear cell carcinoma cell line:TEN	10636-108I6	22.73	3.30	1.91	1.04	0.69	0.69	0.17	0.52	0.35
colon carcinoma cell line:CACO-2	10513-107D9	32.03	6.59	6.41	1.83	1.10	0.37	0.73	0.37	0.73
colon carcinoma cell line:COLO-320	10420-106C6	34.21	13.30	7.60	0.38	0.00	0.00	0.76	0.00	0.38
colon, adult, donor1	10082-102B1	4.76	0.00	0.00	1.19	0.00	0.00	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	12.69	4.11	3.06	0.82	0.12	0.24	0.94	0.12	0.12
colon, fetal, donor1	10070-101I7	6.18	1.85	2.47	0.00	0.62	0.00	1.24	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	233.76	18.33	4.58	0.00	0.00	4.58	0.00	0.00	13.75
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	24.22	17.00	2.12	2.55	1.70	1.70	2.12	0.85	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	28.07	17.36	3.77	1.66	3.17	2.11	1.66	0.91	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	29.33	19.04	3.24	2.68	3.95	2.26	0.99	1.97	0.28
corpus callosum, adult, pool1	10042-101F6	23.33	23.22	5.09	0.55	2.21	2.10	1.44	0.11	0.66
cruciate ligament, donor2	10295-104G7	17.83	11.35	4.05	0.00	1.62	0.00	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	6.42	6.42	1.61	0.00	2.41	0.00	0.00	0.00	0.80
diencephalon, adult	10193-103E4	6.24	7.20	1.68	0.24	2.16	0.72	0.24	0.00	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	43.17	2.07	2.53	0.46	0.23	0.00	0.46	0.23	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	33.85	4.36	2.31	0.26	0.51	0.51	0.00	0.00	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	27.92	9.39	4.81	0.24	1.69	1.93	0.96	0.48	0.00
ductus deferens, adult	10196-103E7	8.97	7.97	3.49	0.00	1.00	0.50	1.00	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	5.76	2.88	2.88	1.44	0.00	0.00	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	13.24	3.68	2.21	0.00	1.47	0.00	0.74	0.00	0.74
dura mater, adult, donor1	10041-101F5	22.38	11.89	5.45	1.16	1.82	0.58	0.83	0.74	0.74
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	21.76	12.44	0.67	0.22	0.44	0.89	0.00	0.67	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	20.92	6.02	1.72	0.86	0.57	0.43	0.29	0.00	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	25.28	7.40	4.32	0.62	0.62	0.00	0.00	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	19.07	4.84	6.66	0.30	0.91	0.00	0.00	0.30	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	25.63	9.57	5.25	1.54	0.00	0.31	0.00	0.00	0.62
embryonic pancreas cell line:2C6	10603-108E9	31.52	9.19	7.88	2.63	1.31	0.00	0.00	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	23.80	2.68	0.67	0.34	0.34	0.34	0.34	0.00	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	39.87	23.74	10.69	1.45	1.45	1.81	0.36	0.00	1.45
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	16.08	3.54	3.22	0.48	0.32	0.16	0.00	0.00	0.48
epidermoid carcinoma cell line:A431	10426-106D3	35.46	7.23	6.67	1.00	0.44	0.22	0.11	0.22	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	35.97	7.81	4.84	0.22	0.88	0.55	0.66	0.33	1.21
epididymis, adult	10197-103E8	9.21	7.12	1.05	0.42	0.84	0.21	0.63	0.21	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	15.08	4.08	2.48	0.35	0.35	0.35	0.00	0.18	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	8.26	1.97	1.57	0.39	0.00	0.39	0.00	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	31.98	6.55	2.75	1.05	0.52	0.66	0.79	0.13	1.31
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	26.67	8.46	4.13	0.59	1.08	0.49	0.69	0.00	1.08
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	34.17	8.18	3.81	1.12	0.78	0.78	0.78	0.00	1.01
esophagus, adult, pool1	10015-101C6	18.05	4.35	4.35	0.32	0.53	0.21	0.11	0.21	0.53
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	36.07	7.39	10.39	0.63	1.50	0.63	0.50	1.38	0.50
eye - muscle inferior rectus, donor1	10272-104E2	4.83	12.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	10.52	12.63	0.00	0.00	4.21	0.00	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	8.93	22.32	1.49	1.49	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	4.59	4.59	1.15	0.00	1.15	2.29	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	10.20	23.32	1.46	0.00	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	7.12	6.36	2.03	0.00	1.78	0.00	0.25	0.00	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	20.13	1.67	2.18	0.26	0.38	0.38	0.51	0.00	0.90
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	22.55	6.17	4.51	0.47	1.19	0.24	0.00	0.24	0.71
frontal lobe, adult, pool1	10040-101F4	7.69	9.19	2.06	0.56	0.94	0.84	0.38	0.09	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	18.01	2.10	5.10	0.30	0.60	0.00	1.20	0.00	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	18.01	3.29	5.12	0.00	0.18	0.00	0.73	0.00	0.55
gall bladder, adult	10198-103E9	8.93	5.31	2.17	0.48	0.97	0.24	1.21	0.00	0.24
gamma delta positive T cells, donor1	11937-126A2	38.65	2.68	2.15	1.07	0.00	0.54	0.54	0.00	2.15
gamma delta positive T cells, donor2	11938-126A3	28.76	5.60	2.99	1.87	0.00	0.00	0.75	0.00	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	15.63	5.28	1.48	1.06	0.42	0.21	0.21	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	21.08	6.38	6.58	0.19	0.39	0.19	0.00	0.00	0.39
gastric cancer cell line:AZ521	10549-107H9	19.02	10.49	6.56	0.16	2.30	3.12	0.49	0.33	0.98
gastric cancer cell line:GSS	10560-108A2	8.24	4.58	1.83	0.00	0.92	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	35.18	7.77	3.43	0.46	0.91	1.14	1.60	0.00	0.46
giant cell carcinoma cell line:LU65	10487-107B1	11.47	1.72	2.07	0.46	0.11	0.00	0.23	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	11.34	4.06	2.94	0.28	0.56	0.14	0.28	0.14	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	25.44	16.21	2.74	0.50	2.24	1.75	1.50	0.00	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	15.62	7.39	2.01	0.84	0.42	0.21	0.53	0.00	0.42
glioblastoma cell line:A172, tech_rep2	10444-106F3	16.57	6.46	2.11	0.98	0.56	0.84	0.14	0.00	0.56
glioblastoma cell line:T98G	10485-107A8	22.19	6.62	2.65	1.21	1.10	0.55	0.22	0.11	0.44
glioma cell line:GI-1	10413-106B8	19.04	2.93	2.34	0.88	0.00	0.00	0.00	0.00	0.29
globus pallidus - adult, donor10196	10175-103C4	18.95	14.58	4.37	0.00	5.10	0.73	0.00	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	33.69	24.41	8.06	0.98	2.69	2.69	1.46	0.00	0.98
globus pallidus, adult, donor10258	10367-105F7	6.85	20.54	2.74	1.37	4.11	0.00	2.74	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	4.80	3.73	1.60	0.00	1.60	0.00	1.07	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	266.74	2.45	14.68	14.68	0.00	0.00	2.45	2.45	7.34
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	0.00	0.00	10.93	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	13.76	3.20	0.64	0.64	0.32	0.00	0.32	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	4.13	1.84	0.46	0.46	0.00	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	5.49	1.37	0.46	0.00	0.00	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	5.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	1.44	2.87	0.00	0.00	0.00	1.44	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	4.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	6.62	11.03	1.10	1.10	1.10	0.00	1.10	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	30.75	8.62	4.02	0.57	0.86	1.15	0.29	0.57	0.29
heart - mitral valve, adult	10205-103F7	8.97	7.18	3.29	0.30	0.90	0.60	0.30	0.00	0.30
heart - pulmonic valve, adult	10206-103F8	9.67	8.63	3.14	0.52	0.52	0.26	0.00	0.00	0.26
heart - tricuspid valve, adult	10207-103F9	21.65	7.49	9.16	0.00	0.00	0.00	2.50	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	7.55	4.29	2.65	0.20	1.22	0.00	0.00	0.00	0.61
heart, adult, diseased, donor1	10051-101G6	2.98	8.52	1.28	0.43	0.85	0.85	0.00	0.00	0.85
heart, adult, pool1	10016-101C7	16.56	10.58	5.52	0.23	1.84	1.15	0.46	0.23	0.46
heart, fetal, pool1	10046-101G1	18.17	11.81	3.29	0.21	1.03	0.72	0.51	0.00	0.92
hepatic mesenchymal tumor cell line:LI90	10778-110G4	16.04	9.56	0.62	0.00	0.93	0.62	0.62	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	32.11	4.76	2.38	0.00	0.00	0.00	2.38	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	31.38	4.75	7.29	0.66	0.66	0.00	0.44	0.11	1.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	39.69	5.22	8.86	0.85	0.73	0.61	0.00	0.00	1.21
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	40.72	4.85	9.80	0.40	0.81	0.40	0.61	0.10	1.82
hepatoma cell line:Li-7	10484-107A7	9.01	1.67	2.22	0.00	0.22	0.11	0.00	0.00	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	40.20	6.83	7.34	0.40	0.50	0.30	0.40	0.60	0.90
hippocampus - adult, donor10196	10169-103B7	5.68	10.41	0.00	0.00	0.00	0.00	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	19.80	12.86	7.14	0.20	1.43	1.02	0.82	0.00	0.20
hippocampus, adult, donor10258	10374-105G5	2.49	4.98	0.00	0.00	2.49	0.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	5.29	1.76	1.41	0.00	0.00	0.70	0.35	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	6.10	1.83	0.61	0.00	0.00	0.00	0.00	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	5.50	0.39	2.16	0.00	0.20	0.00	0.20	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	5.33	1.27	1.27	0.00	0.25	0.00	0.51	0.00	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	6.20	5.64	1.13	0.00	0.56	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	9.04	2.58	1.55	0.26	0.26	0.26	0.26	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	11.77	4.56	2.66	0.00	0.00	0.00	0.00	0.00	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	11.09	9.34	2.04	1.17	0.88	0.00	1.17	0.00	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	8.83	7.54	4.52	0.00	1.08	0.00	0.86	0.00	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	13.35	7.92	0.83	0.42	1.67	0.42	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	19.18	9.71	4.97	0.24	0.95	1.18	0.24	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	12.21	9.00	3.38	0.64	1.61	1.29	1.61	0.00	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	10.10	8.75	3.37	0.00	0.67	2.69	1.35	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	6.57	0.63	2.35	0.00	0.00	0.16	0.31	0.00	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	6.88	0.00	2.46	0.00	0.00	0.00	0.00	0.00	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	6.11	0.00	1.75	0.87	0.00	0.87	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	11.45	5.73	2.86	0.19	0.00	0.19	0.38	0.00	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	10.90	6.54	1.31	0.00	0.00	0.87	0.44	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	11.99	2.50	2.00	0.00	0.00	0.00	0.00	0.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	12.81	8.67	2.26	0.00	0.38	0.00	0.57	0.00	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	18.64	10.00	4.55	0.00	0.45	0.91	0.91	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	8.77	9.08	1.88	0.31	1.25	0.00	0.94	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	6.04	5.72	2.61	0.16	0.98	1.96	0.33	0.00	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	9.00	4.64	3.19	0.29	0.87	1.16	0.29	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	7.17	6.58	1.49	0.30	0.30	0.60	0.30	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	12.38	1.48	0.92	0.00	0.18	0.18	0.37	0.00	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	10.27	2.00	1.14	0.00	0.00	0.29	0.00	0.00	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	12.25	4.08	2.04	0.41	0.00	0.00	1.22	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	14.79	4.93	2.82	0.35	0.70	1.41	0.70	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	12.04	3.48	2.53	0.00	0.32	0.32	0.00	0.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	15.43	4.54	1.51	0.30	0.30	0.30	1.21	0.30	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	21.72	8.27	2.07	0.52	0.52	0.00	1.03	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	11.29	5.31	2.66	1.33	1.33	0.00	1.33	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	9.49	4.87	1.80	0.26	0.77	0.26	0.26	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	13.80	3.32	1.79	0.51	0.51	0.26	0.26	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	10.60	2.27	0.00	0.76	1.51	0.76	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	7.39	7.39	0.67	0.67	0.67	1.68	0.34	0.00	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	12.80	1.45	2.17	0.00	0.00	0.24	0.00	0.00	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	10.25	1.34	1.34	0.45	0.00	0.00	1.34	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	5.85	1.46	0.98	0.00	0.00	0.98	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	16.50	5.50	3.67	0.31	1.22	0.00	0.00	0.00	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	61.81	13.01	6.51	0.00	0.00	0.00	3.25	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	13.57	5.63	1.99	0.00	0.00	0.66	0.66	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	12.59	9.85	1.64	0.55	2.19	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	13.39	7.96	1.81	0.72	0.36	0.00	0.36	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	8.54	8.90	1.42	0.36	0.36	0.71	0.71	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	9.55	3.58	1.19	0.00	1.19	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	15.98	10.83	3.25	0.27	1.35	1.76	0.27	0.00	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	7.00	4.31	2.69	0.54	0.00	1.89	0.54	0.00	0.00
immature langerhans cells, donor1	11904-125F5	9.20	18.16	0.24	4.36	2.66	0.97	0.24	1.94	0.48
immature langerhans cells, donor2	11905-125F6	5.54	24.56	2.38	3.96	0.79	0.00	0.00	3.96	0.00
insula, adult, pool1	10039-101F3	7.29	8.90	2.84	0.66	0.95	0.76	0.19	0.00	0.47
keratoacanthoma cell line:HKA-1	10791-110H8	18.86	2.93	2.28	1.95	0.98	0.00	0.00	0.00	0.33
kidney, adult, pool1	10017-101C8	13.12	3.10	2.20	0.20	0.20	0.20	0.30	0.20	0.50
kidney, fetal, pool1	10045-101F9	13.72	6.22	3.75	0.50	0.42	0.28	0.28	0.14	0.57
large cell lung carcinoma cell line:IA-LM	10509-107D5	10.51	3.69	2.84	0.43	0.57	0.00	0.14	0.14	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	15.07	5.81	2.49	0.28	0.28	0.55	0.00	0.00	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	18.90	7.71	2.57	0.55	0.55	0.37	0.18	0.18	0.00
left atrium, adult, donor1	10079-102A7	3.27	2.72	0.54	0.00	1.09	0.00	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	3.54	6.07	1.52	0.51	1.01	0.00	0.00	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	12.31	10.12	4.10	0.27	0.82	0.82	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	5.03	2.16	1.08	1.08	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	5.98	5.43	1.09	0.54	0.54	1.09	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	13.84	3.64	2.19	0.49	0.49	0.00	0.00	0.00	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	12.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	6.27	0.00	2.09	0.00	0.00	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	45.69	3.42	4.13	0.71	0.24	0.12	0.35	0.35	1.18
liposarcoma cell line:KMLS-1	10782-110G8	11.40	4.22	2.19	0.31	0.47	0.16	0.62	0.00	0.16
liposarcoma cell line:SW 872	10726-110A6	37.28	9.38	2.31	1.46	0.61	0.49	0.12	0.12	0.00
liver, adult, pool1	10018-101C9	7.13	1.62	1.13	0.16	0.16	0.16	0.16	0.00	0.32
liver, fetal, pool1	10086-102B5	2.82	0.00	0.94	0.00	0.00	0.00	0.00	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	12.54	7.00	3.50	0.58	1.90	0.73	0.87	0.00	0.29
locus coeruleus, adult, donor10252	10165-103B3	19.38	12.00	5.35	0.00	1.11	0.55	2.03	0.00	1.48
locus coeruleus, adult, donor10258	10375-105G6	5.36	11.00	0.85	0.56	1.97	1.13	1.69	0.00	0.28
locus coeruleus, newborn, donor10223	10362-105F2	8.41	4.21	0.84	0.84	0.00	0.42	1.26	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	6.64	2.21	2.49	0.14	0.14	0.28	0.14	0.00	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	24.13	2.07	3.45	0.69	0.69	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	17.93	3.56	5.40	0.13	0.40	0.40	0.13	0.00	0.66
lung, adult, pool1	10019-101D1	19.96	4.37	4.02	0.59	0.83	0.12	0.35	0.24	0.83
lung, fetal, donor1	10068-101I5	20.83	7.14	3.42	0.00	1.43	0.29	0.00	0.29	0.57
lung, right lower lobe, adult, donor1	10075-102A3	9.62	5.96	2.75	1.83	0.00	0.00	0.92	0.46	0.46
lymph node, adult, donor1	10077-102A5	11.36	2.84	2.84	0.00	0.47	0.47	0.47	0.47	0.47
lymphangiectasia cell line:DS-1	10727-110A7	26.08	3.29	4.38	0.22	0.44	0.22	0.88	0.22	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	45.73	8.00	2.26	1.81	0.45	0.30	0.60	1.36	0.75
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	29.73	20.39	6.80	0.00	0.85	2.55	0.85	0.00	0.85
mature adipocyte, donor1	12231-129F8	11.10	1.33	0.44	0.44	0.89	0.00	0.89	0.00	0.00
mature adipocyte, donor2	12232-129F9	8.92	2.91	1.25	0.00	0.21	0.00	0.21	0.00	0.00
mature adipocyte, donor3	12233-129G1	4.74	2.13	2.84	0.24	0.00	0.24	0.00	0.00	0.24
mature adipocyte, donor4	12234-129G2	9.74	1.84	1.84	0.26	0.53	0.79	0.26	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	21.21	10.25	6.19	0.24	0.95	0.71	0.00	0.00	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	7.90	10.15	4.51	0.00	2.26	1.13	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	11.22	8.83	3.49	0.18	1.66	0.37	0.55	0.00	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	2.22	6.04	0.95	0.64	0.00	0.00	0.95	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	4.69	9.38	1.71	0.43	0.43	0.00	0.43	1.28	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	6.75	5.23	1.86	0.17	1.52	0.84	0.17	0.00	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	16.98	11.04	2.55	0.21	1.06	1.06	1.49	0.00	1.70
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	1.93	3.85	1.93	0.00	0.00	1.93	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	14.35	0.00	0.00	0.00	43.06	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	2.15	6.82	0.72	0.72	1.44	0.36	0.36	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	15.58	7.79	1.95	0.00	2.60	0.65	1.30	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	20.28	11.77	4.18	0.46	1.24	1.39	0.93	0.00	1.24
medulla oblongata, adult, pool1	10038-101F2	13.39	15.92	3.84	0.24	2.45	1.55	0.90	0.24	0.24
medulla oblongata, newborn, donor10223	10361-105F1	4.51	5.55	1.39	0.35	1.74	1.04	0.69	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	5.98	7.31	0.89	0.00	0.22	0.66	1.33	0.00	0.22
medulloblastoma cell line:ONS-76	10759-110E3	29.71	5.38	4.04	0.61	0.61	0.24	0.24	0.12	0.73
melanoma cell line:COLO 679	10514-107E1	27.31	4.46	2.30	1.29	0.57	0.43	0.14	0.29	0.57
melanoma cell line:G-361	10465-106H6	11.67	2.99	1.09	0.54	0.54	0.81	0.27	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	11.94	3.26	1.63	0.36	0.00	0.36	0.00	0.00	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	60.80	8.81	7.93	0.88	0.88	0.00	0.00	0.00	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	15.55	1.81	1.81	0.00	0.00	0.00	0.00	0.00	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	13.20	5.37	1.23	1.23	0.92	0.31	0.15	0.15	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	9.82	2.36	1.45	0.55	0.36	0.18	0.00	0.00	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	3.73	2.07	0.41	0.83	1.24	0.00	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	8.29	1.97	1.97	0.84	0.70	0.70	0.14	0.00	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	6.35	4.43	1.16	0.77	0.96	0.39	0.00	0.19	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	6.94	0.69	2.08	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	4.81	1.37	0.51	0.17	0.17	0.00	0.00	0.17	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	7.25	3.11	1.50	0.23	0.58	0.12	0.00	0.00	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	16.05	2.39	1.86	0.27	1.06	0.66	0.13	0.13	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	14.31	4.73	1.49	0.41	0.68	0.27	0.00	0.00	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	17.93	2.99	2.70	0.71	0.57	0.00	0.00	0.14	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	6.59	1.65	0.99	0.33	0.00	0.00	0.33	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	13.28	3.46	1.80	0.28	0.69	0.28	0.14	0.14	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	12.22	3.14	0.70	1.40	1.05	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	8.98	5.92	1.22	1.02	0.82	0.82	0.00	0.41	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	5.75	1.80	0.36	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	6.10	0.93	1.34	0.21	0.10	0.00	0.00	0.00	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	4.10	2.28	1.14	0.23	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	18.46	2.52	0.84	1.68	0.84	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	10.16	1.05	0.90	0.75	0.15	0.45	0.00	0.15	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	9.10	2.28	1.23	0.44	0.35	0.09	0.00	0.00	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	11.04	2.95	1.47	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	4.58	5.15	0.86	0.57	0.57	0.00	0.00	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	23.16	6.32	3.79	2.53	2.95	0.42	0.00	0.00	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	10.05	1.83	2.74	1.37	0.46	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	6.65	2.30	1.02	0.51	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	6.81	3.14	0.79	0.79	0.52	0.26	0.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	7.70	4.93	0.92	0.92	0.31	0.00	0.00	0.00	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	6.59	2.59	1.65	0.71	0.24	0.24	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	8.80	2.03	1.35	0.00	1.02	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	5.11	1.57	0.79	1.18	0.39	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	3.24	1.85	0.46	0.46	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	8.08	3.75	1.73	0.87	1.15	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	6.02	2.68	0.89	0.45	0.00	0.22	0.22	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	5.05	2.16	0.48	0.48	0.24	0.24	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	13.20	2.20	0.00	0.73	0.73	0.00	0.00	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	6.71	2.35	0.67	1.34	0.67	0.00	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	3.28	2.87	0.82	0.41	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	3.44	3.87	0.43	0.86	0.43	0.43	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	2.73	5.47	0.00	0.00	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	5.52	1.62	0.97	1.30	0.97	0.32	0.32	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	8.73	2.91	0.00	0.00	1.45	1.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	1.60	1.07	2.13	0.53	0.53	0.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	5.72	0.82	0.00	0.00	0.82	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	5.05	3.50	1.17	1.55	0.39	0.00	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	2.10	4.20	0.00	0.00	2.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	5.96	1.99	0.00	0.00	0.00	0.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	4.77	9.53	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	5.93	3.56	0.59	1.19	1.19	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	3.66	2.44	3.66	1.22	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	6.97	3.17	1.27	0.00	1.27	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	3.79	1.38	0.69	0.34	1.03	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	4.30	0.00	0.00	0.00	0.00	0.00	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	2.04	1.22	1.22	0.00	0.00	0.41	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	1.59	1.59	1.59	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	1.18	2.36	0.59	0.00	0.00	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	2.18	2.18	0.94	0.31	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	1.34	1.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	3.55	2.37	3.55	0.00	1.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	2.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	3.44	2.75	0.00	0.00	0.00	0.69	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	1.48	0.99	0.49	0.49	0.00	0.49	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	2.24	1.12	1.12	2.24	0.00	1.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	4.45	1.27	0.00	0.00	0.00	0.00	0.00	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	3.22	0.81	0.40	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	4.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	2.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	4.25	1.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	0.82	1.65	0.82	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	3.97	0.99	0.79	0.40	0.60	0.20	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	4.87	2.27	0.97	0.00	0.32	0.32	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	1.02	6.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	28.63	7.74	1.55	0.77	0.00	0.00	0.77	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	15.36	7.80	10.16	0.00	0.47	0.00	0.24	0.00	1.18
mesothelioma cell line:ACC-MESO-4	10494-107B8	10.43	3.24	2.55	0.00	0.00	0.23	0.00	0.00	1.16
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	5.45	2.47	0.41	0.21	0.82	0.41	0.10	0.10	0.10
mesothelioma cell line:Mero-25	10850-111F4	17.48	2.27	2.50	0.68	0.23	0.23	0.23	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	10.51	3.67	0.98	0.24	0.24	0.24	0.00	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	13.73	4.43	1.99	0.22	0.22	0.66	0.44	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	14.45	7.36	0.53	1.31	0.26	0.53	0.79	0.53	0.26
mesothelioma cell line:Mero-83	10854-111F8	9.70	3.40	1.02	0.17	0.17	0.17	0.51	0.00	0.00
mesothelioma cell line:Mero-84	10855-111F9	5.06	2.27	1.26	0.00	0.25	0.00	0.00	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	13.46	4.76	3.11	0.21	0.41	0.41	0.00	0.00	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	16.07	8.61	1.82	0.99	0.83	0.50	0.17	0.17	0.17
mesothelioma cell line:NCI-H226	10846-111E9	15.20	1.45	1.09	1.09	0.00	0.54	0.36	0.00	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	17.42	2.56	1.02	1.02	0.00	0.00	0.51	0.17	0.17
mesothelioma cell line:NCI-H28	10845-111E8	7.13	3.82	0.51	0.51	0.25	0.25	0.25	0.00	0.00
mesothelioma cell line:No36	10857-111G2	14.03	0.98	1.96	0.65	0.00	0.00	0.33	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	8.40	3.52	0.27	0.54	0.27	0.54	0.00	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	6.72	2.11	1.15	0.19	0.00	0.00	0.00	0.19	0.58
migratory langerhans cells, donor2	11902-125F3	6.59	1.71	0.85	0.12	0.12	0.00	0.12	0.00	0.24
migratory langerhans cells, donor3	11903-125F4	10.59	3.59	0.90	0.00	0.36	0.18	0.18	0.00	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	21.87	7.51	1.96	0.65	0.33	0.65	0.00	0.00	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	7.42	2.33	1.70	0.00	0.21	0.00	0.21	0.00	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	19.81	7.14	4.15	0.00	0.92	0.92	0.46	0.00	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	26.64	20.93	3.62	2.85	1.71	2.85	0.76	4.38	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	45.46	5.36	2.77	0.92	0.18	0.18	1.48	0.18	1.66
myeloma cell line:PCM6	10474-106I6	6.72	4.55	1.38	0.00	0.59	0.40	0.20	0.20	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	10.65	4.06	2.03	0.00	1.01	0.00	0.00	0.00	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	22.56	7.06	1.77	1.57	0.59	0.98	0.39	0.00	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	10.14	1.67	3.79	0.00	0.11	0.00	0.00	0.00	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	8.02	2.79	2.87	0.07	0.51	0.00	0.07	0.00	0.07
nasal epithelial cells, donor2	12227-129F4	13.25	4.97	2.21	0.55	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	19.10	7.82	4.14	0.46	0.23	0.23	1.15	0.23	0.23
neuroblastoma cell line:NB-1	10539-107G8	55.19	49.20	6.17	3.18	7.11	8.04	2.99	0.94	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	14.55	1.05	1.05	0.21	0.00	0.00	0.42	0.00	0.42
neuroblastoma cell line:NH-12	10555-107I6	27.77	18.45	4.66	0.37	0.37	0.37	1.49	0.00	1.30
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	29.18	0.71	4.03	0.47	0.24	0.00	1.90	0.00	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	31.68	8.08	4.59	3.96	0.32	0.63	3.01	3.01	0.79
neuroectodermal tumor cell line:TASK1	10774-110F9	29.79	2.01	2.62	0.60	0.20	0.00	0.40	0.00	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	39.42	0.64	1.27	2.54	0.00	0.00	0.64	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	10.38	1.86	1.33	0.27	0.27	0.27	0.00	0.00	0.27
neutrophil PMN, donor1	12133-128D9	208.25	14.87	14.87	0.00	0.00	14.87	0.00	0.00	29.75
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	0.00	0.00	0.00	9.47	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	149.16	6.09	7.78	1.01	0.85	0.00	2.54	0.85	3.04
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	11.21	2.40	0.80	0.00	0.80	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	9.30	3.53	0.32	0.64	0.64	0.00	0.00	0.00	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	12.09	2.36	0.79	1.05	0.26	0.26	0.00	0.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	8.81	8.81	2.44	0.28	0.84	1.03	0.19	0.28	0.47
occipital cortex - adult, donor10196	10172-103C1	2.06	6.18	4.12	0.00	2.06	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	19.59	10.20	4.56	0.54	2.95	0.54	1.34	0.00	1.07
occipital cortex, newborn, donor10223	10355-105E4	2.55	2.18	2.55	1.09	0.00	0.36	0.73	0.73	0.00
occipital lobe, adult, donor1	10076-102A4	3.67	5.51	1.05	0.26	0.26	1.31	0.00	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	6.01	5.15	3.43	0.43	0.00	0.43	1.72	0.00	0.43
occipital pole, adult, pool1	10036-101E9	4.57	6.62	1.58	0.08	0.87	0.39	0.00	0.00	0.16
olfactory region, adult	10195-103E6	7.26	9.93	3.25	0.00	1.15	0.96	0.57	0.00	0.19
optic nerve, donor1	10277-104E7	22.01	30.02	6.00	0.00	4.00	2.00	8.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	25.29	10.94	6.26	0.57	1.25	1.59	0.46	0.11	0.91
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	10.58	5.08	5.77	0.00	0.55	0.14	0.69	0.00	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	10.33	2.03	1.52	0.85	0.34	0.00	0.34	0.17	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	28.18	14.32	2.43	0.92	0.92	0.69	0.00	0.12	0.81
osteoclastoma cell line:Hs 706.T	10704-109H2	15.58	5.59	2.06	1.18	0.59	0.29	0.00	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	69.14	7.47	7.47	0.00	0.93	0.93	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	39.44	7.63	4.67	4.45	0.85	0.21	1.06	0.21	0.85
ovary, adult, pool1	10020-101D2	11.62	9.87	4.54	0.44	1.57	0.61	0.26	0.00	0.70
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	13.57	3.30	0.92	1.28	0.00	0.18	0.18	0.18	0.18
pancreas, adult, donor1	10049-101G4	12.23	3.76	4.70	0.00	0.00	0.00	1.88	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	9.50	2.52	4.47	0.00	0.00	0.00	1.12	0.00	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	0.00	0.00	0.17	0.00	0.00	0.00	0.00	0.00	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	33.12	5.96	3.31	0.83	0.66	0.33	0.50	0.33	0.99
paracentral gyrus, adult, pool1	10035-101E8	6.77	8.33	2.75	0.46	0.73	0.46	0.18	0.18	0.00
parietal cortex, adult, donor10258	10373-105G4	5.14	4.40	0.00	0.00	0.00	1.47	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	11.29	7.52	0.00	0.94	0.00	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	8.27	7.41	4.85	0.00	0.29	1.14	1.71	0.00	1.71
parietal lobe, adult, pool1	10034-101E7	8.81	8.20	1.76	0.44	1.50	0.62	0.09	0.09	0.26
parietal lobe, fetal, donor1	10072-101I9	10.67	0.00	3.88	0.00	0.00	0.00	0.97	0.00	1.94
parietal lobe, newborn, donor10223	10356-105E5	4.49	8.97	0.37	0.37	0.75	0.37	1.12	1.50	0.00
parotid gland, adult	10199-103F1	6.78	1.85	1.85	0.00	0.00	0.00	0.62	0.00	0.62
penis, adult	10200-103F2	10.74	5.37	1.61	0.54	1.07	0.54	0.54	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	36.44	10.78	7.25	1.67	0.56	0.74	0.37	0.19	0.93
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	14.57	6.56	3.06	0.29	1.17	0.58	0.87	0.00	0.73
pineal gland - adult, donor10196	10179-103C8	9.68	14.19	1.94	0.00	0.65	0.65	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	13.62	16.58	3.55	0.00	3.55	1.78	1.18	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	3.76	7.52	0.63	0.00	1.25	1.88	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	14.17	15.18	4.05	1.01	1.01	0.00	1.01	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	26.06	25.54	6.78	2.08	3.65	0.52	1.56	0.00	2.08
pituitary gland, adult, donor10258	10378-105G9	5.11	11.92	3.40	0.00	1.70	0.85	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	11.72	2.80	5.38	0.22	0.32	0.22	0.00	0.11	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	26.49	7.02	1.85	0.79	0.40	0.40	0.66	0.40	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	27.39	8.09	2.33	1.56	0.78	0.47	0.31	0.00	1.09
pons, adult, pool1	10033-101E6	7.40	8.35	3.87	0.52	1.55	0.60	0.17	0.00	0.43
postcentral gyrus, adult, pool1	10032-101E5	4.97	8.37	1.48	0.26	0.78	0.70	0.35	0.00	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	117.12	2.09	12.55	0.00	0.00	0.00	0.00	0.00	4.18
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	0.00	5.51	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00	0.00	0.00	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	20.83	2.04	3.93	0.00	0.58	0.15	0.15	0.29	1.17
prostate cancer cell line:PC-3	10439-106E7	23.23	3.27	3.09	0.73	0.54	0.73	0.18	0.18	0.36
prostate, adult, pool1	10022-101D4	15.15	4.17	4.53	0.54	0.91	0.63	0.63	0.09	0.45
putamen, adult, donor10196	10176-103C5	9.68	4.49	2.83	0.24	0.71	1.42	1.18	0.00	0.47
putamen, adult, donor10252	10152-102I8	21.57	9.80	5.88	0.00	0.00	3.92	1.96	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	2.19	4.37	0.00	1.09	0.00	1.09	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	5.32	5.32	1.45	0.97	0.48	0.48	0.00	0.00	0.00
putamen, newborn, donor10223	10365-105F5	0.75	6.75	1.50	0.00	0.00	0.75	0.75	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	24.73	7.27	6.40	0.00	1.45	0.58	0.00	0.00	0.87
rectum, fetal, donor1	10067-101I4	18.08	13.91	4.17	2.78	0.00	0.00	0.00	0.00	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	17.60	0.85	1.06	0.42	0.00	0.00	0.00	0.00	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	4.14	0.41	0.00	0.00	0.00	0.00	0.41	0.00	0.83
retina, adult, pool1	10030-101E3	11.43	12.23	3.78	0.40	0.89	0.89	1.19	0.40	0.99
retinoblastoma cell line:Y79	10475-106I7	33.77	8.83	7.01	1.56	1.04	0.52	1.82	0.00	1.30
rhabdomyosarcoma cell line:KYM-1	10787-110H4	25.45	4.92	11.56	0.12	0.37	0.74	0.49	0.00	1.11
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	18.84	4.50	2.25	0.00	0.28	0.00	0.00	0.00	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	13.64	3.03	2.27	0.00	0.00	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	7.61	3.56	1.62	0.00	0.32	0.32	0.49	0.16	0.00
salivary acinar cells, donor2	11772-123I8	6.33	5.37	1.38	0.00	0.41	0.00	0.41	0.00	0.00
salivary acinar cells, donor3	11773-123I9	13.24	13.90	4.63	0.66	1.32	0.00	0.66	0.00	0.66
salivary gland, adult, pool1	10093-102C3	14.30	2.29	2.86	0.57	1.14	0.00	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	17.54	6.91	2.78	0.34	1.01	0.34	0.25	0.59	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	17.16	5.17	2.59	0.35	0.94	0.24	0.24	0.35	0.94
seminal vesicle, adult	10201-103F3	8.99	7.41	1.06	0.53	0.00	1.06	0.53	0.00	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	14.33	7.29	1.94	0.97	0.73	0.73	0.00	0.00	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	7.80	6.29	1.01	0.25	0.50	0.00	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	18.06	9.03	1.00	0.00	2.01	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	11.42	4.43	2.96	0.00	0.54	0.00	0.00	0.00	0.67
signet ring carcinoma cell line:Kato III	10436-106E4	32.05	5.86	3.98	0.99	0.22	0.44	0.66	0.11	0.55
signet ring carcinoma cell line:NUGC-4	10483-107A6	21.29	6.84	1.55	2.32	0.65	0.13	0.00	0.39	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	8.51	20.57	2.84	0.71	2.84	2.13	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	17.75	23.27	4.92	0.84	2.16	1.20	0.00	0.00	0.72
skeletal muscle, fetal, donor1	10066-101I3	5.03	4.02	0.00	0.00	0.00	0.00	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	6.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	17.04	7.57	5.68	1.26	2.52	1.89	0.63	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	45.69	5.34	5.34	0.33	0.67	0.33	0.67	0.00	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	11.66	4.73	4.73	0.00	0.32	0.00	1.26	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	16.00	4.63	4.63	0.19	0.58	0.00	0.77	0.00	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	30.66	3.13	2.97	0.33	0.16	0.00	0.33	0.16	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	22.84	4.18	2.90	0.32	0.16	0.00	1.29	0.16	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	21.14	4.36	2.62	0.87	0.22	0.22	0.44	0.00	0.87
small intestine, adult, pool1	10024-101D6	12.78	3.46	3.58	0.48	0.12	0.12	0.84	0.24	0.36
small intestine, fetal, donor1	10064-101I1	6.88	4.18	0.98	0.25	0.49	0.00	0.00	0.00	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	34.88	7.69	7.69	2.05	1.03	0.51	0.51	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	6.46	4.14	3.36	0.26	0.78	0.00	0.52	0.00	0.26
somatostatinoma cell line:QGP-1	10781-110G7	35.91	7.50	8.31	0.27	0.80	0.00	0.54	0.00	0.80
spinal cord - adult, donor10196	10181-103D1	11.01	9.64	2.29	0.00	1.15	0.46	0.69	0.00	0.46
spinal cord, adult, donor10252	10159-103A6	24.84	14.59	7.10	1.18	3.94	2.76	1.18	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	11.07	13.14	0.00	1.38	1.38	1.38	0.69	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	12.81	7.93	3.05	0.61	2.44	0.00	1.83	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	14.24	11.48	0.92	0.46	2.76	0.00	1.84	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	20.16	5.82	2.09	1.64	0.90	0.00	0.00	0.00	0.60
spleen, adult, pool1	10025-101D7	22.69	2.64	2.53	0.55	0.11	0.44	0.44	0.00	0.33
spleen, fetal, pool1	10044-101F8	26.54	3.89	3.97	0.64	0.56	0.16	0.32	0.00	0.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	19.25	1.97	1.97	0.10	0.41	0.00	0.31	0.10	0.62
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	26.39	5.51	7.97	0.38	0.19	0.19	0.19	0.00	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	5.94	4.19	2.10	0.35	0.00	0.35	0.00	0.00	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	17.98	3.91	3.52	0.78	0.39	0.00	0.00	0.00	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	15.42	4.05	2.93	0.34	0.11	0.34	0.11	0.00	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	9.32	1.69	1.69	0.00	0.00	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	27.50	12.27	3.81	0.00	1.27	1.27	0.00	0.00	0.85
stomach, fetal, donor1	10062-101H8	21.36	7.48	5.34	1.07	0.00	0.00	1.07	0.00	2.14
submaxillary gland, adult	10202-103F4	21.65	3.99	2.85	0.00	1.14	0.57	0.57	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27	0.00	0.00	0.00	0.00	217.10	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	24.30	17.24	5.19	0.62	1.04	1.66	3.12	0.00	1.66
substantia nigra, adult, donor10258	10371-105G2	5.17	6.21	1.55	0.00	1.55	1.03	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	9.19	4.95	0.00	0.00	2.12	0.71	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	47.69	3.67	13.53	0.46	0.23	0.46	1.15	0.00	1.60
temporal lobe, adult, pool1	10031-101E4	5.00	6.95	1.95	0.25	0.59	0.51	0.08	0.00	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	9.26	7.12	3.56	0.00	0.00	0.71	1.42	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	7.47	5.27	2.64	0.00	0.44	0.44	1.32	0.00	0.00
tenocyte, donor1	11763-123H8	14.31	1.75	1.75	0.00	0.00	0.35	0.00	0.00	1.75
tenocyte, donor2	11765-123I1	12.59	1.53	2.29	0.38	0.00	0.00	0.38	0.00	0.76
tenocyte, donor3	11768-123I4	12.60	3.71	2.22	1.85	0.00	1.11	0.00	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	12.07	7.82	2.89	0.00	0.51	0.85	0.17	0.00	0.68
teratocarcinoma cell line:NCR-G1	10798-110I6	30.37	7.24	3.39	1.85	0.15	0.77	1.39	0.00	0.62
teratocarcinoma cell line:PA-1	10807-111A6	14.26	2.01	1.70	0.00	0.15	0.31	0.31	0.00	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	14.22	1.78	3.17	0.00	0.00	0.00	0.51	0.00	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	7.56	1.13	0.76	0.00	0.00	0.38	0.38	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	17.12	0.33	1.42	0.00	0.00	0.00	0.33	0.44	0.44
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	10.42	1.30	1.95	0.00	0.33	0.00	0.65	0.00	0.33
testis, adult, pool1	10026-101D8	11.38	5.69	3.44	0.11	0.75	0.21	0.21	0.11	0.11
testis, adult, pool2	10096-102C6	6.77	3.61	1.80	0.00	1.80	0.90	2.26	0.00	0.00
thalamus - adult, donor10196	10168-103B6	17.66	15.46	1.10	1.10	1.10	1.10	1.10	0.00	0.00
thalamus, adult, donor10252	10154-103A1	28.44	18.75	4.69	0.63	2.19	1.09	2.50	0.00	0.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	7.70	12.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	2.96	5.11	0.16	0.00	0.82	1.15	0.82	0.00	0.00
thalamus, newborn, donor10223	10366-105F6	2.30	1.73	0.00	0.00	0.00	0.00	0.58	0.00	0.00
throat, adult	10209-103G2	7.99	7.99	1.75	0.50	1.00	0.25	1.00	0.00	0.00
throat, fetal, donor1	10061-101H7	11.27	12.49	3.66	0.30	0.91	0.00	0.91	0.00	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	31.00	2.19	7.15	0.99	0.20	0.00	0.99	0.00	0.79
thymus, adult, pool1	10027-101D9	65.22	2.29	6.36	2.78	0.30	0.10	0.50	0.10	1.79
thymus, fetal, pool1	10043-101F7	47.17	3.12	6.55	2.08	0.10	0.10	0.73	0.21	1.56
thyroid carcinoma cell line:KHM-5M	10776-110G2	21.81	5.32	2.53	0.27	0.53	0.40	0.00	0.13	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	14.53	3.77	2.51	0.42	0.56	0.00	0.70	0.00	1.54
thyroid, adult, pool1	10028-101E1	17.73	9.89	4.85	0.00	0.65	0.56	0.28	0.00	0.37
thyroid, fetal, donor1	10060-101H6	9.49	8.44	2.11	0.00	1.58	0.53	1.85	0.00	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	27.72	9.24	6.16	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	10.23	9.07	2.33	0.00	0.93	0.23	0.23	0.00	0.23
tongue, fetal, donor1	10059-101H5	5.91	5.52	1.97	0.00	1.58	0.79	0.00	0.00	0.79
tonsil, adult, pool1	10047-101G2	37.77	5.31	3.81	1.30	0.40	0.30	0.90	0.30	1.20
trachea, adult, pool1	10029-101E2	20.12	5.24	5.40	0.74	0.65	0.41	0.16	0.08	1.06
trachea, fetal, donor1	10058-101H4	14.62	2.31	1.92	0.38	0.38	0.00	1.15	0.00	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	11.34	5.67	3.19	1.06	1.06	0.35	0.35	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	26.65	1.72	2.33	0.61	0.20	0.41	0.51	0.10	0.61
transitional-cell carcinoma cell line:JMSU1	10492-107B6	20.53	6.11	3.92	0.00	0.78	0.16	0.16	0.31	0.31
tridermal teratoma cell line:HGRT	10694-109G1	22.83	5.71	3.81	0.00	0.00	0.00	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	13.97	6.01	2.79	0.34	0.25	0.25	0.08	0.08	0.42
umbilical cord, fetal, donor1	10057-101H3	4.17	4.17	2.09	0.00	0.00	0.00	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	14.84	9.90	3.92	0.51	0.68	0.85	0.17	0.17	0.17
uterus, fetal, donor1	10055-101H1	11.77	7.17	3.58	0.51	1.02	0.00	1.02	0.00	0.51
vagina, adult	10204-103F6	20.03	3.88	3.88	0.00	1.29	0.00	1.29	0.00	0.00
vein, adult	10191-103E2	27.18	3.73	1.97	0.44	0.66	0.00	0.00	0.22	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	13.89	1.34	0.80	0.53	0.00	0.27	0.53	0.27	0.80